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ABSTRACT

FLUORESCENCE IN SITU HYBRIDIZATION ANALYSIS OF
HUMAN EMBRYOS DERIVED FROM
IN VITRO AND IN VIVO MATURED OOCYTES
Constance DeScisciolo
Old Dominion University
Eastern Virginia Medical School
August 1997
Director: Dr. Susan Lanzendorf
Despite adequate hormonal stimulation, oocytes collected for the
purpose of in vitro fertilization and embryo transfer display several levels of
nuclear maturity. Preovulatory or mature oocytes, technically those that are
Metaphase I or II, are inseminated shortly after aspiration and assessed for
fertilization the following day. Prophase I oocytes, also called germinal vesiclebearing or immature oocytes, require a 24-36 hour period in culture before
being exposed to spermatozoa. During this time, the majority of Prophase !
oocytes complete nuclear maturation in vitro, progressing from germinal vesicle
breakdown through first polar body extrusion. If inseminated, many in vitro
matured oocytes fertilize and appear to develop normally. However, compared
to embryos derived from mature oocytes, embryos derived from Prophase I
oocytes produce significantly fewer pregnancies following intrauterine transfer.
To determine if the reduced developmental potential of embryos derived from
Prophase I oocytes can be explained in part by an increase in nuclear and/or
genetic abnormalities, this study used Fluorescence In Situ Hybridization
analysis to compare 65 embryos derived from oocytes that were Metaphase I or
II at aspiration to 61 embryos derived from oocytes that were Prophase I at
aspiration. Although there was no difference in the incidence of multinucleated
blastomeres in the two groups, embryos derived from Prophase I oocytes had a
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significantly higher incidence of both anuclear blastomeres and blastomeres
with a fragmented nucleus compared to their counterparts derived from mature
oocytes. Because nuclear fragmentation is a hallmark of programmed cell
death and subsequent apoptosis, which has been implicated in the processes
of follicular atresia in vivo and cleavage arrest in vitro, we speculate that
Prophase I oocytes obtained following controlled ovarian hyperstimulation
originate from follicles in early stages of atresia. This study found no difference
in the rate of aneuploidy for chromosomes X, Y, and 18, or in the incidence of
mosaicism involving these chromosomes in the two groups of embryos.
However, according to our classification system, 23% of embryos derived from
Metaphase I or II oocytes were normal compared to only 3% of embryos derived
from Prophase I oocytes. Our findings suggest that few embryos derived from
Prophase I oocytes are normal, perhaps explaining in part why they rarely
establish pregnancies in our IVF program.
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I.

INTRODUCTION

At or shortly after birth, the human ovary consists of millions of follicles,
each containing an oocyte that has begun meiosis only to become arrested
early in the first meiotic division at a stage referred to as the dictyate stage. The
nucleus of the oocyte, defined as the germinal vesicle, has become arrested in
Prophase I of meiosis, and will remain arrested throughout childhood.
Following the maturation of the hypothalamic-pituitary-ovarian axis that occurs
at puberty, a 28-35 day reproductive cycle is established. During each cycle,
under appropriate hormonal stimulation, a group of follicles is “recruited” to
begin growth and development. Approximately halfway through the cycle, a
gonadotropin (follicle stimulating hormone and luteinizing hormone, called FSH
and LH respectively) surge occurs, inducing the resumption of meiosis in a
single oocyte, that within the “dominant follicle". The remaining follicles, and the
oocytes within, will have succumbed to atresia at various stages of
development. Progression of this oocyte through germinal vesicle breakdown
(GVBD) to first polar body extrusion follows, and ovulation ensues. The nucleus
of the ovulated oocyte is once again arrested, this time in metaphase of the
second meiotic division (Metaphase II), and it will remain arrested until
fertilization occurs. This description of oogenesis and the more detailed one
that follows, represent decades of work by many investigators as reviewed by
Byskov (1982), Baker (1982), and Wassarman and Albertini (1994).
Reproductive endocrinologists have developed controlled ovarian
hyperstimulation (COH) protocols which utilize the exogenous administration of
gonadotropic hormones to increase the number of mature oocytes available for
assisted reproductive techniques. By artificially increasing the serum level of
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FSH, the cohort of developing follicles can avoid the usual "selection” phase in
which all but the dominant follicle undergo atresia, allowing the oocytes in all of
the recruited follicles to achieve growth and maturation. Prior to ovulation, the
oocytes are collected in a transvaginal, ultrasound-guided procedure, and used
for in vitro fertilization and embryo transfer (IVF-ET). Despite adequate
hormonal stimulation, these fully-grown oocytes demonstrate various levels of
nuclear maturity. Preovulatory, or “mature" oocytes, technically those in
Metaphase I or Metaphase II of meiosis, are inseminated shortly after collection
and assessed for fertilization the following day. Prophase I oocytes, also called
germinal vesicle bearing or “immature” oocytes, must be cultured for 24-36
hours to permit germinal vesicle breakdown and first polar body extrusion
before being exposed to spermatozoa. Despite the fact that the majority of such
in vitro matured oocytes do fertilize and appear to cleave normally, the resulting
embryos demonstrate an extremely low incidence of pregnancy following
intrauterine transfer when compared to embryos derived from oocytes that were
mature at collection (Reviewed by Edwards and Brody, 1995).
The reduced developmental potential of embryos derived from in vitro
matured oocytes is well-documented but poorly understood. The purpose of this
study was to compare the rate of aneuploidy and the incidence of mosaicism in
embryos derived from in vitro matured oocytes to that observed in embryos
derived from in vivo matured oocytes using Fluorescence In Situ Hybridization
(FISH), a technique with proven application for the genetic analysis of human
embryos.

A. Oogenesis
Oogenesis, the formation, growth, and maturation of the oocyte, begins
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early in fetal life when, under the influence of two X chromosomes, (and in the
absence of a Y chromosome), the primitive bipotential gonads begin to
differentiate into ovaries. Primordial germ cells, identifiable as early as 24 days
after conception, migrate from extra-embryonic sites to a region of tissue called
the genital ridge located on the ventral surface of the primitive kidney, the
mesonephros. Upon arrival at the genital ridge, which will form an ovary in the
female, the germ cells are called oogonia. As a result of vigorous mitotic
activity, their number rapidly increases from 600,000 at eight weeks of gestation
to nearly 7,000,000 by twenty weeks of gestation. Upon entering meiosis, a
process which begins around 12 weeks of gestation immediately following
sexual differentiation, the oogonia are called oocytes. During the second half
of fetal life, the number of oocytes falls to approximately 2,000,000 at birth. This
dramatic decline is the result of chromosomal breaks and other errors leading to
oocyte degeneration that occur early in the first meiotic division, as described
below.
Meiosis, a series of two cell divisions in which the number of
chromosomes is reduced from diploid to haploid, begins before birth and is not
truly completed until, or unless, sperm penetration occurs following ovulation,
many years later. The first meiotic division begins shortly after the last mitotic
division of the oogonium is completed. Following interphase, in which the DNA
is replicated in preparation for meiosis, the primary oocyte enters Prophase I.
This phase is exceptional for two reasons. First, it is during Prophase I that
crossing over takes place and second, Prophase I is characterized by a
prolonged resting phase in females during which development is arrested.
Prophase I can be divided into five stages called leptotene, zygotene,
pachytene, diplotene, and diakinesis. Leptotene begins when, in cytological
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preparations, the diploid number of chromosomes can be identified, each
chromosome comprised of two identical chromatids. During zygotene,
homologous chromosomes of maternal and paternal origin associate and
eventually attach forming pairs called “tetrads" in a manner so precise that
homologous genes associate with one another. “Crossing over”, in which the
exchange of genetic material between pairs of homologous chromosomes
occurs, happens during pachytene. Diplotene is characterized by the
separation of homologous chromosomes except at those places in which
crossing over has occurred, termed chiasmata. Crossing over is critical in that
this reassortment of genes ensures that the genetic material of the oocyte is
unique.
In humans, Prophase I is completed through diplotene in all oocytes at
or shortly after birth. The oocytes then enter a prolonged resting stage termed
dictyate or the dictyotene stage. Although meiosis is arrested during dictyate,
(which lasts throughout childhood until puberty, when the maturation of the
hypothalamic-pituitary-ovarian axis occurs), dictyate is not truly a “resting
stage”. Cytoplasmic organelles such as Golgi apparatus, endoplasmic
reticulum, and ribosomes are present in oocytes at dictyate, and both
transcription and translation actively occur (Telford et al., 1990; Wassarman and
Kinloch, 1992). The “lampbrush” chromosomes present, characteristic of those
found in the oocytes of many vertebrate and invertebrate species, bear lateral
projections which replicate ribonucleic add (RNA). Since transcription ceases
at the time of ovulation (Telford et al., 1990), this RNA guides protein synthesis
in the oocyte and organizes the early development of the embryo following
fertilization until activation of the embryonic genome occurs, believed to be
between the 4- 8 cell stage in the human (Braude et al., 1988).
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The term “primordial follicle” is given to the oocyte at dictyate when it
becomes surrounded by a single layer of cuboidal “theca” cells. These layers
increase in number by mitosis, until the oocyte, in its arrested meiosis, is
surrounded by several layers of cells called granulosa cells. These cells, along
with the oocyte itself, participate in the formation of the zona pellucida, a
mucoid material which ultimately surrounds the oocyte. Granulosa cell
processes penetrate the zona pellucida, contacting the oocyte in various
regions, permitting exchange of both substrates and waste materials.
Eventually, follicular fluid accumulates in the spaces between the granulosa
cells, and the follicle is said to be vesicular. These spaces coalesce to form a
single antrum, transforming the follicle into a preovulatory or Graafian follicle.
The process of follicular growth described above, resulting in the
development of vesicular and finally Graafian follicles from that of the primordial
type, begins shortly before birth and continues throughout childhood in a small
fraction of the follicle pool at all times. Before the onset of puberty, all such
growing follicles undergo degeneration at some point in their development, a
process called follicular atresia, due to a low serum FSH level. Thus, of the
2,000,000 oocytes present at birth, about 250,000 remain at the age of seven
years. At the onset of puberty, approximately 150,000 are viable. Following the
maturation of the hypothalamic-pituitary-ovarian axis that occurs at puberty, a
28-35 day reproductive cycle is established. Only at this time, with the correct
hormonal support (i.e. FSH), is a growing follicle allowed to proceed to the point
of ovulation. During each cycle, although many follicles begin to grow, only one
oocyte is induced to resume meiosis and proceed to ovulation. The remaining
follicles undergo atresia. During a woman’s reproductive lifetime, no more than
400 oocytes are normally ovulated.
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Shortly before ovulation, approximately 36 hours in the human female,
there is a dramatic increase in the release of gonadotropins from the pituitary
gland, termed the “LH surge”. This surge results in the final maturation of the
Graafian follicle, inducing a wave of mitosis in the granulosa cells. Those cells
immediately adjacent to the oocyte, the cumulus oophorous, become columnar
in shape and eventually separate from the remaining membrana granulosa,
rendering the oocyte "free-floating” within the follicle or loosely attached to the
follicle wall.
The LH surge also induces the resumption of meiosis in the oocyte to be
ovulated. Meiosis progresses to diakinesis, also called the germinal vesicle
stage since the nucleus of the oocyte at this time is defined as the germinal
vesicle. Thus, the prophase of the first meiotic division begun so long ago is
finally completed. Metaphase I is rapidly followed by Anaphase I and then
Telophase I. Homologous chromosomes separate, and an unequal division of
cytoplasm occurs, resulting in a rather large secondary oocyte and a small first
polar body. Meiosis continues to Metaphase II, which in the human female
represents another stage of arrested development similar to dictyate. It is at this
time that ovulation generally occurs. Completion of the second meiotic division
is dependent upon penetration of the oocyte by a spermatozoon at fertilization,
and an unequal division of cytoplasm occurs once again, resulting in the
extrusion of a small second polar body.
Great strides have been made in recent years toward understanding
gene expression during oogenesis. Maturation-promoting factor (MPF), a
protein dimer consisting of a catalytic subunit composed of a serine threonine
kinase, and a regulatory subunit composed of cyclin-B (Pines and Hunter,
1989), is a key regulatory component of the cell cycle in both meiotic and mitotic
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cells (Murray et al., 1991). During oogenesis, two peaks of MPF activity have
been demonstrated (Mattioli et ai., 1991). The first one occurs at the resumption
of meiosis following dictyate, and the second during meiotic arrest at
Metaphase II. The proto-oncogene c-mos has been implicated in the upregulation of MPF activity that occurs at both these times (Sagata et al., 1989).
The protein product of c-mos is a kinase which enhances MPF activity directly
by phosphorylating the cyclin-B subunit (Roy et al., 1990), and indirectly by
interfering with its proteolytic degradation (O’Keefe et al., 1991). A study
performed at the Jones Institute (Heikinheimo et al., 1995) supports the theory
that c-mos messenger RNA is a stored maternal message that is translated in a
temporally-specific manner during oogenesis, allowing c-mos kinase to play a
vital role in meiotic maturation.

B. In Vitro Maturation of Qocvtes
Despite vast improvements in the success of assisted reproduction for
the treatment of infertility, from the cryopreservation of human embryos to the
use of intracytoplasmic sperm injection (ICSI) for the achievement of
fertilization, there has been little success with the maturation of human oocytes
in the laboratory. As mentioned earlier, oocytes collected following COH for the
purpose of IVF-ET display varying levels of nuclear maturity. Preovulatory, or
mature oocytes, those which have been induced to resume meiosis in vivo, are
inseminated shortly after collection. These oocytes demonstrate high
fertilization rates in vitro and, upon transfer to the uterus, the resulting embryos
initiate significantly more pregnancies than embryos derived from oocytes that
were Prophase I at collection.
Prophase I oocytes are cultured for 24-36 hours before being reassessed
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for maturity, it has been the Norfolk experience that by this time, the majority
(80%) have achieved meiotic competency, progressing from germinal vesicle
breakdown through first polar body extrusion (Veeck, 1984). Upon
insemination with freshly prepared spermatozoa, approximately 80% of such “in
vitro matured” oocytes fertilize and appear to undergo normal development.
However, when the resulting embryos are transferred to the uterus, an
extremely low incidence of pregnancy (4%) is realized (unpublished data from
the Jones Institute data base).
Despite the fact that COH protocols producing the greatest number of
mature oocytes are utilized, approximately 22% of the oocytes collected for the
purpose of IVF-ET are Prophase I (unpublished data from the Jones Institute
data base). Several investigators have modified in vitro culture conditions,
generally believed to be suboptimal, in an attempt to improve in vitro maturation
rates, and enhance the development and pregnancy potential of embryos
derived from oocytes matured in vitro.
Prins and coinvestigators (1987) reported that immature oocytes cultured
for 24-34 hours in medium supplemented with LH and FSH demonstrate higher
maturation rates (73.5% versus 35.6%) and fertilization rates (64.0% versus
36.4%) than control oocytes cultured under standard conditions. The authors
were unable to determine if gonadotropin supplementation of culture medium
increased the ability of these oocytes to initiate pregnancy, as the resulting
embryos were transferred with embryos derived from oocytes matured in vivo.
Other attempts to improve the in vitro maturation and development of
immature oocytes collected following COH have utilized coculture. This
technique, which involves culturing oocytes and embryos along with various
somatic cells such as epithelial cells and fibroblasts from numerous sites, or
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granulosa cells, is an effort to mimic the environment within the ovarian follicle.
Dandekar et al. (1991) reported that “immature oocytes" cultured with
granulosa cells obtained from preovulatory follicles from the same patient
demonstrated higher maturation and fertilization rates compared to “immature
oocytes” cultured without granulosa cells (59% versus 35% and 54% versus
20% respectively). Unfortunately, nuclear maturation was not assessed in this
study and oocytes were classified as “immature” based solely on cumulus and
corona morphology rather than on the presence of a germinal vesicle, in
addition, because the embryos were transferred along with embryos derived
from in vivo matured oocytes, the authors were unable to determine if there was
a difference in the pregnancy potential between the two groups.
Janssenswillen and coworkers (1995) reported that human cumulus-free
immature oocytes cultured with green monkey kidney epithelial cells (Vero
cells) demonstrate a higher maturation rate than similar oocytes cultured in
medium alone. Thirty hours after collection, 82% of the immature oocytes in the
coculture group progressed to first polar body extrusion compared to 38% of
those cultured in medium alone. Because all in vitro matured oocytes were
used for other studies, the authors were unable to assess their fertilization and
further development.
Using the cynomolgus monkey model, Lanzendorf and coinvestigators
(1996) have shown that the developmental potential of embryos derived from
immature oocytes is significantly improved following cocuiture with Vero ceils.
In this study, 40% of embryos derived from in vitro matured oocytes reached the
expanded blastocyst stage when cultured with Vero cells compared to 0% when
cultured in medium alone. Interestingly, embryos derived from in vivo matured
oocytes did not benefit from coculture, reaching the expanded blastocyst stage
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at a rate of 33% in both treatment groups. The authors concluded that embryos
derived from in vitro matured oocytes differ in culture requirements when
compared to embryos derived from oocytes matured in vivo.
The studies described above demonstrate that it is possible to improve
the developmental potential of Prophase I oocytes on two levels: at the level of
the oocyte, by improving in vitro maturation and fertilization rates; and, at the
level of the embryo, by improving development to the expanded blastocyst
stage. However, because embryos derived from Prophase I oocytes are rarely
transferred alone, it is unclear if these improvements translate into
improvements in pregnancy rates.
The fact that some Prophase I oocytes undergo maturation, fertilization,
and normal development in vitro and, upon transfer to the uterus, are capable of
implanting and progressing to live births, is of great interest to infertility
specialists. It suggests that, in the future, IVF-ET may be possible with little or
no exogenous hormonal stimulation, particularly if the developmental potential
of in vitro matured oocytes improves such that it approximates that of oocytes
matured in vivo during COH. This is extremely important given the fact that the
long-term effects of COH on the patient remain largely unknown. In addition to
the possibility that there is an association between ovarian stimulation and an
increased risk of ovarian cancer, the severe form of ovarian hyperstimulation
syndrome, although rare, represents a critical illness (Edwards and Brody,
1995).
The developmental potential of Prophase I oocytes is also of great
interest for another reason. Although the cryopreservation of mature human
oocytes has met with little success, Toth and coworkers (1994) have reported
that Prophase I human oocytes, obtained from both stimulated and unstimulated
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ovaries, are able to survive cryopreservation and undergo nuclear maturation in
vitro following thaw. The oocytes obtained from unstimulated ovaries were not
inseminated, but those obtained from stimulated ovaries, upon insemination,
demonstrated fertilization and cleavage rates similar to that of control oocytes.
Although the cryopreservation of Prophase I oocytes may be an option for
women, particularly those anticipating loss of ovarian function following
extirpative therapy, radiation, or chemotherapy, the low pregnancy rate realized
after intrauterine transfer of embryos derived from these oocytes remains a
serious concern.
Cytogenetic analyses of Metaphase II human oocytes obtained after
ovarian hyperstimulation have been limited not only by the scarcity of material,
but also by the inefficiency of the karyotyping procedure. These studies have
consistently found, however, that many such oocytes are aneuploid, containing
a chromosomal constitution different from the normal haploid constitution by
loss or duplication of one or more chromosomes or chromosome segments.
Van Blerkom and Henry (1992) reported that 25-40% of mature oocytes
collected after COH are aneuploid, and suggested that this may result from
exposure to abnormal follicular conditions during a critical point in maturation.
This is in sharp contrast to a 1-3% aneuploidy rate in Prophase I oocytes
allowed to undergo maturation in vitro (VanBlerkom, 1989). It must be noted,
however, that the immature oocytes in this study were obtained from
unstimulated ovaries, and whether or not this low aneuploidy rate applies to
immature oocytes collected following COH remains unknown. Indeed the fact
that the follicles containing Prophase I oocytes were able to be identified and
punctured during the retrieval, suggests at least a limited exposure and
response to the gonadotropins used for stimulation. This suggests that the
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Prophase I oocytes collected after COH may be different from those obtained
from unstimulated ovaries, but this remains to be seen.
Mammalian oocytes released from follicles and placed in culture
undergo meiotic maturation spontaneously (Pincus, 1935; Edwards, 1965;
Eppig, 1985), provided they have reached a species-specific minimum size
(Iwamatsu, 1975; Sorensen, 1976; Lanzendorf, 1992; Durinzi, 1995).
Investigators have shown that increased levels of intracellular cAMP maintain
meiotic arrest in vitro (Schultz, 1983), and that a significant decrease in the
intracellular cAMP level precedes GVBD in the oocyte, both in vitro and in vivo
(Dekel, 1980). It has been suggested that a cAMP-dependent protein kinase
modulates the phosphorylation/dephosphorylation of various proteins in the
oocyte which in turn regulate meiotic maturation (Bomslaeger, 1986; Schultz,
1983). In addition, there is evidence suggesting a role for intracellular calcium
levels ( Bomslaeger, 1984), steroid hormones (Eppig, 1983), and gonadotropins
(Freter, 1984), as well as oocyte maturation inhibitor (OMI), a product of
granulosa cells (Tsafriri, 1982). It is likely the regulation of meiosis in the
mammalian oocyte is a complex system involving many or all of the factors
mentioned above, but a detailed regulatory pathway remains elusive.
Despite success in the cattle industry, in which oocytes are routinely
obtained from unstimulated ovaries and used for IVF-ET (Goto, 1988; Fukui,
1989), attempts to mature human oocytes obtained from unstimulated ovaries in
the laboratory have met with limited success. However, three pregnancies
resulting from in vitro-matured oocytes have been reported. In the first report,
healthy triplet girls were delivered following the in vitro maturation and
fertilization of oocytes recovered from ovariectomy specimens and used for
donation (Cha et al., 1991). In the other two pregnancies, immature oocytes
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were aspirated from the follicles of infertile patients without prior ovarian
stimulation. Following in vitro maturation of the recovered oocytes, two
pregnancies resulting in normal, live births were established (Trounson et al.,
1994; Barnes e t al., 1995). Although these reports are both encouraging and
exciting, much research is needed before immature oocyte recovery and use for
the establishment of pregnancy becomes routine in the treatment of human
infertility.
It has been suggested that although oocytes matured in the laboratory
undergo normal nuclear maturation, perhaps their cytoplasmic maturation is
impaired. Using the cynomolgus monkey model, investigators transferred
ooplasm, a technique they called ooplasmic transfusion, from in vivo matured
Metaphase II oocytes into Prophase I oocytes. A delivery rate of 13% was
realized when, following nuclear maturation, the transfused oocytes were
returned to the fallopian tube for fertilization. The authors suggest that in vitro
matured oocytes lack a cytoplasmic factor found in oocytes matured in vivo,
which, if replaced, improves their developmental potential (Flood, 1990).
Despite impressive strides made in recent years, there remains
considerable mystery surrounding the female gamete, the oocyte.
Folliculogenesis, described briefly above, in which several follicles are
“recruited” to begin growth and development in a given reproductive cycle, is
poorly understood. Investigators are at a loss to explain why some follicles
become part of this developing “cohort” while neighboring follicles, seemingly
identical, remain unaffected. It has been suggested that when meiosis is
“asynchronized”, as it is in humans, the first oocytes to enter meiosis during fetal
life will be among the first recruited for further development later on, but this
remains to be proven. In addition, scientists don’t fully understand how one
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oocyte, that within the “dominant follicle”, is selected to resume meiosis while
those within the remaining follicles in the cohort succumb to atresia at various
stages of their development. A working theory, however, has gained wide
acceptance (Hodgen, 1982).
Considering the complex nature of all that mammalian oogenesis
achieves, from bestowing genetic uniqueness on the female gamete, to
synthesizing the macromolecules and organelles necessary for normal
fertilization and early embryogenesis, it is not surprising that attaining the ability
to carry out and investigate this entire process in the laboratory has proven a
great challenge.

C. Fluorescence In Situ Hybridization For The Analysis Of Human Embrvos
Fluorescence in situ hybridization (FISH) is a very powerful tool for the
genetic analysis of blastomeres from human embryos. Used in conjunction with
COH and IVF for the production of numerous embryos, and embryo biopsy, for
the removal of one or two blastomeres from cleavage stage embryos, FISH has
successfully been used for the preimplantation diagnosis of genetic sex and
aneupioidy in human embryos prior to transfer. In addition, several
investigators have used FISH to detect chromosome abnormalities in cleavagearrested and morphologically abnormal human embryos, as well as in excess
and “deselected” embryos, those not transferred or cryopreserved following a
stimulated cycle.
FISH analysis involves hybridizing fluorochrome-labelled ONA probes
specific for regions of selected chromosomes to the fixed interphase nuclei of
blastomeres. Fluorescence microscopy then allows direct visualization of the
selected chromosomes, permitting numerical chromosome analysis. Because
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several probes labeled with different fluorochromes can be hybridized
simultaneously, FISH allows assessment of ploidy as well.
The preimplantation genetic diagnosis of sex allows the selective transfer
of female embryos following IVF in couples at risk of transmitting X-linked
disorders. FISH is currently the preferred method for embryo sexing with clear
advantages over the previous method, DNA amplification via the polymerase
chain reaction (PCR), in that it provides information on sex chromosome
number, and is less susceptible to contamination by foreign ONA (Grifo et
al.,1994; Griffin et al.,1994; Harper et al.,1994).
Following evaluation of 20 cleavage-arrested or abnormally developing
monospermic embryos using FISH with ONA probes specific for chromosomes
X,Y,18,13, and 21, Munne and coworkers (1993) reported that 70% contained
numerical aberrations of these chromosomes, including errors in ploidy,
mosaicism (the presence of two or more different cell lines within a single
embryo), and aneupioidy. Similar evaluation of 10 normally developing
monospermic embryos from patients with a mean age of 40 years found that
70% of these embryos were abnormal as well, with sex chromosome
aneupioidy being the most common abnormality.
A similar study evaluating 131 cleavage-arrested or morphologically
abnormal embryos using FISH with DNA probes specific for chromosomes X, Y,
and 18 found numerical aberrations in 56.5% of the embryos (Munne et
al.,1994). In this study, most of the abnormal embryos were polyploid or
mosaic. The authors suggest that, if it were possible to evaluate all
chromosomes simultaneously, the vast majority of cleavage-arrested and
abnormally developing embryos would likely be found to carry numerical
chromosome abnormalities.
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In April 1995, Munne and coworkers published a study using FISH to
evaluate 31 normally-developing human embryos, those that had reached the
6-8 cell stage by Day 3 of development with <15% fragmentation, even cells,
and few or no vacuoles or multinucleated blastomeres. These embryos came
from two sources: embryos determined to be male following preimplantation
diagnosis of sex in couples at risk of transmitting X-linked disorders, and
therefore desiring the selective transfer of female embryos; and, embryos
donated for research by patients over 40 years of age, since cryopreservation
rarely increases the chance of pregnancy in these patients. Using probes
specific for chromosomes X.Y.18, and 16, the investigators determined that 23%
of normally-developing embryos carried numerical abnormalities involving
these chromosomes. And, if diploid embryos containing one or more tetraploid
cells are considered abnormal, then this percentage increased to 49%.
Although the aneupioidy rate tended to increase with maternal age, the
differences did not reach statistical significance possibly due to a small sample
size.
In a larger study evaluating 524 monospermic embryos with FISH using
either three (X,Y, and 18) or five (X,Y,18,13, and 21) DNA probes
simultaneously, Munne and coinvestigators (1995) correlated embryo
morphology, developmental rate, and maternal age with numerical
chromosome abnormalities. They reported that while polyploidy and
multinucleation are the main chromosome abnormalities found in cleavagearrested embryos, aneupioidy is the main chromosome abnormality in normallydeveloping embryos obtained after COH/IVF. In addition, the incidence of
aneupioidy increases significantly with maternal age, reaching 37.2% in
normally-developing embryos from patients 40 years or older.
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The application of FISH for the genetic analysis of human embryos in
recent years has had a large impact on the field of assisted reproduction. We
have learned that a large proportion of embryos obtained following COH/IVF
are genetically abnormal, including many with normal morphology, perhaps
explaining in part, why so few embryos implant and progress to live births upon
transfer to the uterus. Also, the occurrence of genetic abnormalities in human
embryos increases significantly with maternal age, a fact of great importance
considering that the average age of patients seeking treatment for infertility has
increased over the past several years. In addition, the application of FISH in the
area of preimplantation genetic diagnosis has led to the exciting possibility that,
in the future, routine screening of human embryos after COH/IVF will allow the
selective transfer of fewer, genetically normal embryos in all patients, thereby
increasing the efficiency of IVF/ET while, at the same time, decreasing the
incidence of multiple births. This possibility will soon be explored at The Jones
Institute for Reproductive Medicine.
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II.

STATEMENT OF PURPOSE

Despite adequate hormonal stimulation, oocytes collected following
controlled ovarian hyperstimulation for the purpose of IVF-ET display several
levels of nuclear maturity. Mature (Metaphase I or II) oocytes are inseminated
shortly after retrieval and assessed for fertilization the following day. Prophase I
(immature) oocytes are cultured for 24-36 hours before being exposed to
spermatozoa. Of those that complete nuclear maturation in vitro during this
time, progressing from germinal vesicle breakdown through first polar body
extrusion, approximately 50% fertilize and appear to undergo normal
development. However, an extremely low incidence of pregnancy is realized
following intrauterine transfer of the resulting embryos. From January of 1986
through March of 1997, there were 4098 embryo transfers performed at the
Jones Institute in which all embryos were derived from mature oocytes. Of
these, 1177 (29%) resulted in clinical pregnancies. In contrast, of 96 embryo
transfers performed during the same time period in which all of the embryos
were derived from Prophase I oocytes, only 4 (4%) resulted in clinical
pregnancies (unpublished data, Jones Institute database).
The reduced developmental potential of embryos derived from Prophase
I oocytes is well documented and, as a result, ovarian hyperstimulation
protocols producing the greatest number of mature oocytes are utilized in IVF
programs. Embryos derived from Prophase I oocytes are transferred only when
a sufficient number of embryos derived from mature oocytes is unavailable. In
many cases, Prophase I oocytes are discarded or used in research protocols.
Given the fact that last year, 22% of all oocytes aspirated at the Jones Institute
were Prophase I (unpublished data, Jones Institute database), it is obvious that
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in order improve the success rate and increase the efficiency of IVF-ET for our
patients, we need to improve the developmental potential of Prophase I
oocytes. Increasing our understanding of their reduced developmental
potential, the goal of this study, is a first step toward this end.
The purpose of this study was to test our hypothesis that the reduced
developmental potential of embryos derived from Prophase I oocytes can be
explained in part by an increase in nuclear and/or genetic abnormalities in
these embryos. We used Fluorescence In Situ Hybridization analysis with DNA
probes specific for chromosomes X, Y, and 18 to compare the rate of
aneupioidy and the incidence of mosaicism in embryos derived from oocytes
that were Prophase I at aspiration to that observed in their counterparts derived
from oocytes that were Metaphase I or II at aspiration.
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III.

EXPERIMENTAL TECHNIQUES

A. Materials
The hormones, human menopausal gonadotropin (Pergonal) and human
follicle stimulating hormone (Metrodin) used for ovarian hyperstimulation of
patients at The Jones Institute for Reproductive Medicine were obtained from
Serono Laboratories, Inc. (Norwell, MA). Leuprolide acetate (Lupron) was
obtained from TAP Pharmaceuticals (Deerfield, IL). Falcon plasticware was
used for tissue culture and sperm preparation (Becton Dickinson, Franklin
Lakes, NJ). Hams F-10 culture medium and Dulbecco's phosphate buffered
saline were supplied by GIBCO Laboratories (Grand island, NY). Human serum
albumin and synthetic serum substitute were obtained from Irvine Scientific
(Santa Ana, CA). Percoll, sodium citrate, bovine serum albumin, methanol, and
glacial acetic acid were purchased from Sigma Chemical Company (St. Louis,
MO). The following materials, used in the preparation of Acid Tyrodes solution,
were also obtained from Sigma Chemical Company: sodium chloride,
potassium chloride, calcium chloride, magnesium chloride, glucose, and
polyvinylpyrrolidone (PVP-40). Propanediol was supplied by Fisher Scientific
(Pittsburgh, PA). Formamide was obtained from United States Biochemical
(Cleveland, OH). The DNA probe mixtures, saline sodium citrate (SSC), NP-40,
and DAPI (4’,6-diamino-2-phenyl-indole) were purchased from Vysis (Downers
Grove, IL).

B. Equipment
Oocytes and embryos were evaluated using a Nikon Diaphot inverted
microscope (Nikon, Garden City, NY) equipped with Hoffman optics (Hoffman
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Modulation Contrast, Greenvale, NY). Embryos were cryopreserved and later
thawed in a Planer Kryo 10, Series II programmable biological freezer obtained
from T.S. Scientific (Perkasie, PA). Blastomere isolation and fixation was
performed under a Nikon SMZ-10 dissecting microscope. Rxed nuclei were
located using a Nikon Labophot-2 phase contrast microscope, and their
locations recorded with a Reid Rnder microscope slide obtained from Rsher
Scientific. Fluorescence microscopy was performed on a Nikon Microphot-FX
epifluorescent microscope, and the single bandpass filter sets for viewing both
green and red fluorochromes were supplied by Nikon. The single bandpass
aqua filter set and the triple bandpass filter set were obtained from Vysis.

C. Human Embryos
Embryos for this study were obtained from two sources. The first source
was cryopreserved embryos donated by IVF patients of the Jones Institute for
Reproductive Medicine. Patients no longer wishing to keep their embryos
cryopreserved are sent a form entitled “Authorization for Utilization or
Disposition of Cryopreserved Pre-zygote(s)/Preembryo(s) at the Jones Institute"
(Appendix B). One option they may choose is to donate their embryos for use in
approved research. The use of such embryos for this study is covered by a
protocol reviewed and approved by the Institutional Review Board of Eastern
Virginia Medical School (IRB Approval #07-08-93-0043; Appendix A1).
A second source of embryos was obtained as follows: Prophase I
oocytes were donated by non-male-factor IVF patients and oocyte donors at
The Jones Institute for Reproductive Medicine. After overnight incubation in
culture medium, the oocytes were inseminated with sperm samples obtained
from the spouse in the case of IVF patients, or from consenting sperm donors in
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the case of oocyte donors. The use of these embryos is covered by the protocol
mentioned above (IRB Approval #07-08-93-0043; Appendix A1). The consent
forms for oocyte and sperm donors are found in Appendices A2 and A3.

D. Methods
1. In Vitro Fertilization and Embrvo Culture
Because this study utilized human embryos donated for research by
former IVF patients which were in cryostorage for varying numbers of years,
laboratory protocols differed. In addition, procedures such as stimulation
protocol, sperm preparation, and oocyte insemination are routinely
individualized and tend to vary slightly according to each patient’s specific
needs.
Ovarian hyperstimulation was accomplished as previously described for
the Norfolk program (Muasher.1992). Briefly, hMG (Pergonal) alone, FSH
(Metrodin) alone, or a combination of hMG/FSH with or without pituitary
suppression using a GnRH analog (Lupron) under long or short protocols were
utilized. Transvaginal oocyte retrieval was performed 34-36 hours after human
chorionic gonadotropin (hCG) administration.
Culture conditions for oocytes and embryos, as well as in vitro fertilization
procedures, were as previously described for the Norfolk program
(Veeck,1991). Culture of oocyte and embryos occurred in organ culture dishes
kept at 5% C02 in air under humidified conditions. Incubation medium
consisted of modified Ham’s F-10 supplemented with human fetal cord serum,
human serum albumin, or synthetic serum substitute. Sperm was prepared by
either standard swim-up methods or after Percoll gradient centrifugation.
Insemination concentration was dependent upon sperm morphology. Oocytes

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

23

were classified according to nuclear maturity at aspiration, and inseminated as
follows: Metaphase II oocytes, 3-5 hours after aspiration; Metaphase I oocytes,
3-5 hours after first polar body extrusion; Prophase I oocytes, 24-29 hours after
aspiration. Oocytes were evaluated for the presence of pronudei 12 to 19
hours after insemination.
Immediately before transfer, which occurred on the morning of Day 2 or 3
following fertilization, embryos were evaluated for cleavage status and their
morphology graded using criteria previously published (Veeck, 1991). Grade 1
represented a perfect morphological condition and Grade 5 an embryo with
severe or complete fragmentation. The grade of the embryo with the best
morphology was recorded as the grade of the transfer.
2. Crvopreservation and Thawing Protocols
Cryopreservation of pronuclear stage embryos was performed before 20
hours post-insemination using a slow freezing protocol in a programmable
Planer Kryo 10, Series II biological freezer as previously described (Veeck et
al., 1993). Freezing medium consisted of 1.5 M propanediol in modified
Dulbecco’s phosphate buffered saline. Embryos were placed into cryovials
containing 0.3 mL of freezing medium, and allowed to equilibrate at room
temperature for 30 minutes before being loaded into the freezer. The
temperature within the freezer was cooled to -6QC at a rate of 10 C/ minute.
After a 5 minute hold, each cryovial was manually seeded. Following an
additional 5 minute hold, the temperature within the freezer was cooled to
-800 c at a rate of 0.50 Cl minute. Each cryovial was then plunged directly into

liquid nitrogen for storage.
The thawing procedure was performed in the Planer biological freezer in
a similar manner. After cooling the freezer to -1000 C, the cryovials containing
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the embryos to be thawed were loaded. The temperature within the freezer was
warmed to room temperature at a rate of 80 C/ minute. After a 5 minute hold,
the embryos were removed from the cryovials, and taken through a series of
decreasing concentrations of 1,2 propanediol for 5 minutes in each dilution (1.0
M, 0.5 M, and dPBS without propanediol). The embryos were washed and
placed in equilibrated culture medium.
3. Blastomere Isolation and Fixation
Following evidence of normal fertilization (i.e. the presence of two
pronuclei 12-20 hours post-insemination), or, in the case of cryopreserved
embryos, survival of the thawing procedure, embryos were cultured in Hams F10 medium supplemented with 15% Synthetic Serum Substitute for 48 hours.
Each embryo was placed briefly (2-3 seconds) in acidified Tyrodes solution
(Hogan et. al., 1986) to effect zona pellucida removal, and then washed and
transferred to a culture dish containing calcium and magnesium-free
Dulbecco’s phosphate buffered saline for 10-15 minutes to decrease cell-to-celi
contacts. Blastomere separation was facilitated by gentle pipeting through a
fine-drawn glass pipet. Individual blastomeres were placed in a hypotonic
solution consisting of 1% sodium citrate and 6 mg/ml bovine serum albumin for
5 minutes, during which time they were evaluated for nuclear status under an
inverted microscope. Figure 1 shows a representative blastomere with a single
nucleus (A), one with multiple nuclei (B), and one found to be anuclear (C).
Although the nuclear status before fixation was recorded, this was sometimes
found to be incorrect, especially in cases where the cytoplasm demonstrated
excessive granularity. For this reason, all blastomeres were fixed, even if a
nucleus could not be identified under the inverted microscope. The absence of
a nucleus in blastomeres was not a failure of the fixation procedure, since
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Fig. 1 Individual blastomeres from human embryos
examined under the inverted microscope with Hoffman
modulation contrast. (A) Blastomere with a single nucleus;
(B) Multinucleated blastomere with 2 nuclei; (C) Anuclear
blastomere. Original magnification x 400.
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cytoplasm was present and could be readily identified on the slide. Also, some
blastomeres lacked a distinct, membrane-bound nucleus but a clear, lightened
area was present within the cytoplasm. Some of these blastomeres were found
to contain metaphase chromosomes (Figure 2B).
Following the 5-minute incubation in hypotonic solution, individual
blastomeres were transferred to a glass microscope slide. All slides were
previously cleaned with methanol and marked with a small circle on the bottom
using a diamond tip pen indicating the approximate location of the nucleus.
Immediately before the microdroplet dried, 8.5 uL of fixative (methanol/acetic
acid 3:1) was dropped on top of the blastomere, lysing the cell membrane and
fixing the nucleus. The fixative was prepared fresh and stored on ice during the
procedure. Gentle blowing across the slide was used to free the nucleus of
remaining cytoplasm. The fixed nucleus was immediately located using a
phase contrast microscope. Rgure 2 shows a single nucleus (A), two nuclei (B),
and a metaphase spread (C) viewed under the phase contrast microscope.
These were obtained following the fixation of three individual blastomeres. The
first was a mononuclear blastomere (A); the second was a multinucleated
blastomere with 2 nuclei (B); and the third was a blastomere in which a distinct,
membrane-bound nucleus was not visible under the inverted microscope. The
location of the nucleus (or nuclei) was recorded with a Reid Finder microscope
slide. All slides were stored at 8° C until the FISH procedure was performed.
4. Fluorescence In Situ Hybridization
FISH was performed using a mixture of DNA probes specific for
chromosomes X,Y, and 18 directly labeled with Spectrum Green, Spectrum
Orange and Spectrum Aqua fluorochromes respectively. The hybridization
target for chromosome X was DXZ1. The hybridization target for chromosome Y
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Fig. 2 Photographs taken with a phase contrast
microscope following the fixation of three individual
blastomeres. (A) A single nucleus from a mononucleated
blastomere; (B) Nuclei from a multinucleated blastomere
with two nuclei; (C) Metaphase chromosomes obtained
from the fixation of a blastomere in which a distinct,
membrane-bound nucleus was not visible under the
inverted microscope. Original magnification x 600.
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was DY21. The hybridization target for chromosome 18 was D18Z1. The
probes were purchased pre-denatured and pre-mixed with appropriate
hybridization buffer. Each nucleus, fixed onto an individual glass microscope
slide, was denatured in the following way: 100 uL of denaturing solution
consisting of 70 uL formamide, 10 uL 20X SSC, and 20 uL water, was placed
on top of the nucleus and covered with a 22 mm x 40 mm coverslip. The
microscope slide was then placed on a glass plate in an oven at 80° C for 5
minutes. After removing the coverslip, the denatured nucleus was dehydrated
in an ethanol series (70%, 85%, 100%) for 1 minute in each dilution. Each slide
was allowed to air dry before being placed on a slide warmer at 50° C for 2-3
minutes. Two uL of the probe mixture was applied to the target area and
covered with a small coverslip prepared by quartering a 22 mm x 22 mm
coverslip using a diamond tip pen. After excluding air bubbles, the coverslip
was sealed with rubber cement. Hybridization was allowed to proceed
overnight in a moist chamber at 37° C. The post-hybridization washes used to
remove excess probe consisted of a 2 minute wash in 0.4X SSC/0.3% NP-40 at
73° C followed by a 1 minute wash in 2X SSC/0.1% NP-40 at room
temperature. After allowing the slides to air dry protected from direct light, 10 uL
DAPII counterstain was applied to the target area and covered with a 22 mm x
22 mm coverslip.
Fluorescence microscopy for evaluation of the nuclei was performed on a
Nikon epifluorescent microscope equipped with four single bandpass filter sets:
a filter set for viewing ultraviolet light was used to locate the DAPIcounterstained nuclei; a filter set for viewing green fluorochromes was used to
identify chromosome X; a filter set for viewing red fluorochromes was used to
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visualize chromosome Y; and a filter set for viewing the aqua fluorochrome was
used to identify chromosome 18. In addition, a triple bandpass filter set which
allows simultaneous viewing of all three fluorochromes was used to photograph
the nuclei. Figure 3 shows the nucleus of a blastomere obtained from a human
embryo viewed with the ultraviolet filter (A), and the triple bandpass filter (B)
showing a normal male complement (XX1818). A computerized image
analysis system was not used at any time. Initial location of the nucleus was
performed using the Reid Finder microscope slide and the coordinates
recorded during the fixation procedure,
a. Scoring Criteria
The scoring criteria described by Hopman and coworkers (1988) were
followed. Signals of low intensity, most likely the result of cross-hybridization to
non-target DNA, were not scored. Double signals, two signals found close
together or interconnected which may represent sister chromatids or split
signals due to the nature of the target alphoid sequences, were scored as one
signal.
In addition, since all or most of the blastomeres from each embryo were
analyzed, the criteria described by Munne et al. (1995) were used to distinguish
FISH failure from true mosaicism:
1) Blastomeres with one signal per chromosome analyzed were considered
haploid cells.
2) Blastomeres with three or more signals per chromosome analyzed were
considered polyploid cells.
3) Embryos in which all of the blastomeres analyzed contained the same
abnormality, whether aneupioidy, haploidy, or polyploidy, were considered
genetically abnormal.
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Fig. 3 FISH analysis using probes for chromosomes
X (green), Y (red), and 18 (blue) of a nucleus from a
blastomere obtained from a human embryo. (A) DAPIcounterstained nucleus viewed with an ultraviolet filter
set; (B) The same nucleus viewed with a triple bandpass
filter set showing a normal male complement (XY1818).
Original magnification x 600.
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4) Embryos in which sibling blastomeres had extra or missing signals
compensating for those missing or extra in another blastomere were considered
“compensated mosaic” embryos.
5) All other blastomeres with more or less than two signals for each
chromosome analyzed were considered FISH failures.
In addition, blastomeres with a nucleus observed under phase microscopy
following fixation, but either not found or covered by debris following FISH
analysis, were considered FISH failures.
b. Lymphocyte Controls
Lymphocyte control slides, prepared using standard cytogenetic
technique, were used to determine the efficiency of the FISH procedure. A total
of 300 nuclei obtained from a healthy male were scored.
c. Embrvo Classification
The following definitions were used to classify the embryos:
Normal: An embryo in which all blastomeres analyzed contain a single nucleus
with the same normal diploid complement.
Mosaic: An embryo containing blastomeres with two or more different genetic
complements, indicating the presence of two or more different cell lines. In a
diploid mosaic, one of the cell lines is a normal diploid complement. Also
included in this group are all embryos with one or more multinucleated
blastomeres and/or blastomere(s) with a fragmented nucleus.
Aneuploid: An embryo in which all of the blastomeres analyzed contain the
same genetic abnormality.
Abnormal Nuclear Morphology: An embryo in which 50% or more of the
blastomeres demonstrated abnormal nuclear morphology, i.e. they were either
multinucleated or contained a fragmented nucleus. Rgure 4 illustrates the

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

32

difference between a multinucleated blastomere (A) and one containing nuclear
fragments (B). In a multinucleated blastomere, the nuclei, which usually
number two but occasionally number 3 or more, are roughly the same size and
round in shape. In a blastomere with a fragmented nucleus, many (>5) smaller,
irregularly-shaped pieces of nuclear material are present.
5. Statistical Analysis
Data was collected on two groups of embryos. One group (Immatures)
consisted of 61 embryos derived from oocytes that were Prophase I at
collection, and the other group (Matures) consisted of 65 embryos derived
from oocytes that were either Metaphase I or II at collection. Patient information
was compared between the two groups using unpaired t-tests for the following
continuous variables: age at retrieval, # amps of hMG administered, # amps
FSH administered, # mature oocytes aspirated, # mature oocytes that fertilized
normally, and the # of embryos transferred. Comparisons between the two
groups were made with contingency table analysis (Chi-square) for categorical
variables: stimulation protocol, highest transfer grade, establishment of a fresh
pregnancy, and establishment of a cryo pregnancy.
Comparisons between the two groups with respect to embryo information
were made as follows. An unpaired t-test was used to compare the mean
number of blastomeres per embryo. A Chi-square test was used to compare the
number of embryos in each group classified as Normal, Mosaic, Aneuploid, and
containing Abnormal Nuclear Morphology according to the classification system
outlined above. Chi-square tests were used to compare embryo classification
with the following variables: patient age, type of infertility, stimulation protocol,
highest grade of embryo(s) transferred, and fresh and cryo pregnancy status. In
addition, a Chi-square test was used to compare the number of blastomeres in
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Fig. 4 Phase contrast photographs illustrating the

difference between a multinucleated blastomere (A) and
a blastomere containing a fragmented nucleus (B). The
blastomeres were obtained from two different human
embryos. Original magnification x 600.
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each group that were lost during fixation, were anuclear, contained a single
nucleus, contained multiple nuclei, contained a fragmented nucleus or nuclei,
and contained metaphase spreads, independent of the embryos from which
they came. Non-parametric rank tests were used to compare the number of
blastomeres in each group that were lost during the FISH procedure, were lost
during fixation, were anuclear, contained a single nucleus, contained multiple
nuclei, contained a fragmented nucleus or nuclei, and contained metaphase
spreads.
6. Photography
Embryos and individual blastomeres were evaluated and photographed
using a Nikon inverted microscope equipped with Hoffman optics and Kodak
Technical Pan film (ASA 100). The fixed nuclei were evaluated and
photographed using an Olympus phase-contrast microscope and Kodak
Technical Pan film (ASA 100). Fluorescent signals were evaluated and
photographed using a Nikon epifluorescent microscope and Kodak Gold film
(ASA 400).
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IV.

RESULTS

A. Patient Information. Transfer Status, and Pregnancy Outcome
A total of 130 cryopreserved pronuclear stage embryos derived from
oocytes that were mature (Metaphase I or II) at collection were donated by 27
patients in 28 stimulated cycles. Sixty-nine embryos survived the thaw for an
overall survival rate of 53%. Two of these embryos were found to contain one
pronucleus at thaw, and both arrested at this stage of development. Three
embryos were lost before fixation. In addition, one of these patients also
donated 2 cleavage-stage embryos, and one of these embryos survived the
thaw and was included in the study. A final count of 65 embryos derived from
mature oocytes were analyzed. These embryos were donated by 17 patients in
17 stimulated cycles. One patient was an oocyte recipient, and the remainder
were infertility patients using their own oocytes. The types of infertility were as
follows. There were 4 patients with tubal factor infertility, 3 with luteal phase
defects, 3 with male factor infertility, 2 with immunologic factors, 2 with idiopathic
infertility, 1 with endometriosis, and 1 with an ovulatory defect. Twelve (71%) of
the patients received luteal lupron. Two patients (12%) received follicular
lupron. Three patients (18%) received no lupron.
There were 64 embryos derived from oocytes that were Prophase I at
aspiration donated by 23 patients in 27 stimulated cycles. Ten of these
embryos were cryopreserved at the pronuclear stage. Three embryos did not
survive the thaw, leaving 61 embryos from 23 patients for analysis. Twenty-one
of these patients were oocyte donors. The remaining 2 were infertility patients,
one diagnosed with polycystic ovaries and the other with tubal infertility. All
patients received luteal lupron.
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Comparisons between the two groups, designated as M ature and
Immature based on the nuclear status of the oocyte at aspiration, were as

follows. The average age of patients in the M ature group was 35.5 +/- 2.7
years compared to 28.0 +/- 3.8 years for patients in the Immature group. This
difference was statistically significant (p < .0001). Table 1 presents information
on various IVF parameters collected in an attempt to compare the patient
response to stimulation between the two groups. Note that the fertilization rate,
the number of embryos transferred, embryo grade, and pregnancy outcomes for
oocyte donors in the Immature group actually pertain to their respective
recipients). In other words, these values were achieved with those oocytes,
mature at aspiration, received by the recipients. Twenty-two oocyte donors had
one recipient and 3 had two recipients. The fertilization rate was significantly
higher in the Mature group than in the Immature group (88% vs. 67%, p =
0.00001). No other differences were statistically significant (Table 1).

B. Maturation and Fertilization of Proohase I Qocvtes
Of 176 Prophase I oocytes aspirated, 159 were inseminated. Of those
inseminated, 71 fertilized normally, for a fertilization rate of 44.7%. Results on 7
embryos were lost to technical difficulties early in the study. As mentioned
above, 3 of 10 embryos that were cryopreserved did not survive the thaw,
leaving 61 embryos derived from Prophase I oocytes for analysis. The mean
number of Prophase I oocytes aspirated per cycle was 6.5 +/- 4.1 and ranged
from 2 to 16. The mean number of Prophase I oocytes inseminated per cycle
was 5.9 +/- 3.7 and ranged from 1 to 15. The mean number of Prophase I
oocytes that fertilized normally per cycle was 2.6 +/-1.7 and ranged from 1 to 6.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission

TABLE 1.

Group

IVF Parameters For Mature Oocytes In the Mature and Immature Groups

No. Mature Oocytes
Aspirated

Fertilization
Rate(%)

No. Embryos
Transferred

Embryo Grade
1or2(%)

Fresh Pregnancy
Rate(%)

Cryo Pregnancy
Rate(%)

Mature

15.5+/-10.9

231/264(88)®

3.4+/- 1.4

24/27(89)

6/15(40)

5/8(63)

Immature*

16.1 +/-6.8

291/436(67)®

3.7+/-1.3

13/15(89)

14/27(53)

4/5(80)

® p = .00001
* Information on fertilization, transfer, and pregnancy outoome refer to mature oocytes received by recipient(s),
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C. Nuclear Status of Individual Blastomeres
A total of 331 blastomeres from 65 embryos were analyzed in the
M ature group. A total of 342 blastomeres from 61 embryos were analyzed in

the Immature group. The mean number of blastomeres per embryo was 5.1
+/- 2.3 and 5.6 +/- 2.6 for the Mature and Immature groups respectively (NS).
Table 2 presents the nuclear status of the individual blastomeres independent
of the embryos from which they came. Also included are those blastomeres
lost during the fixation procedure. The M ature group contained a significantly
greater percentage of blastomeres with a single nucleus than the Immature
group (56% vs. 33%, p < .0001). The Im m ature group had a significantly
greater percentage of blastomeres with a fragmented nucleus or nuclei than
the Mature group (19% vs. 3%, p < .0001). The Immature group also had a
significantly greater percentage of anuclear blastomeres than the Mature
group (33% vs. 25%, p = 0.0181). No other differences were statistically
significant (Table 2).

D. Oocvte Maturity and Embryo Classification
Table 3 presents the classification of each of the embryos analyzed
according to the system outlined in the Methods section. A significantly greater
percentage of embryos in the Mature group were classified as Normal
compared to embryos in the Immature group (23% vs. 3%, p = 0.0012). A
significantly greater percentage of Immatures were classified as Abnormal
compared to Matures (64% vs. 35%, p = 0.0014). No other differences were
significant (Table 3). In addition, if the mosaic embryos in each group are
reevaluated disregarding multinucleated blastomeres and blastomeres
containing a fragmented nucleus (i.e. considering mononucieated blastomeres
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TABLE 2.

Nuclear Status of Individual Blaatomeres In the Mature and Immature Groups

Group

Single Nucleus
(%)

Multiple Nuclei
(%)

Mature

185(56)*

44(13)

Immature

114(33)*

3?(11)

Fragmented
Nucleus (%)

Anuclear
(%)

Metaphase
Spreads (%)

Lost During
Fixation (%)

Total

11 (3)b

82(25)c

2(1)

7(2)

331

113(33)°

9(3)

4(1)

342

65(19)b

* p < 0001
b p < .0001
° p = .0181

w

(£>
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TABLE 3.

Group

Mature
Immature

Normal
(%)

15/65(23)3
2/61 (3)a

Aneuploid
(%)

0 (0)
2/61(3)

Oocyte Maturity and Embryo Classification

Mosaic
(%)

22/65(34)
14/61(23)

Abnormal Nuclear
Morphology (%)

23/65 (35)b
39/61 (64)b

Didn't Cleave
(%)

Technical
Failure (%)

3/65(5)
3/61(5)

2/65(3)
1/61(2)

a p = .0012
b p = ,0014

4*.

O
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only), 15/65 (23.1%) of embryos in the Mature group are mosaic compared to
13/61 (21.3%) of embryos in the Im m ature group. This difference is not
statistically significant Results of the FISH analysis of each individual
blastomere of all embryos in both groups are presented in Appendix C.
Tables 4 and 5 present oocyte maturity and embryo classification for
embryos with less than 4 blastomeres and embryos with 4 or more
blastomeres respectively. There were no significant differences between the
Mature and Immature groups when only those embryos with less than 4

blastomeres were considered (Table 4). However, when only those embryos
with 4 or more blastomeres were considered, a significantly greater percentage
of Matures were normal compared to Immatures (30% vs. 4%, p = 0.0009). A
significantly greater percentage of Immatures were classified as having
abnormal nuclear morphology compared to Matures (64% vs. 28%,
p = 0.0006) (Table 5).

E. Other Patient Variables and Embrvo Classification
There were no significant relationships between the following patient
variables and embryo classification for either Matures or Immatures: patient
age (p = 0.1509 and p = 0.6385 respectively); highest embryo grade at transfer
(p = 0.3983 and p = 0.3831 respectively); and establishment of a pregnancy (p
= 0.0971 and p = 0.6075 respectively). In the Mature group, there was no
significant relationship between the following types of infertility and embryo
classification (p = 0.1328): idiopathic, immunologic, luteal phase defect, male
factor, and tubal factor infertility. There were too few embryos in the remaining
groups (endometriosis, ovulatory, polycystic ovarian disease) for statistical
analysis. Also in the Mature group, there was no significant relationship
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TABLE 4.

Oocyte Maturity and Embryo Classification for Embryos With Less Than 4 Blastomeres

Group

Normal
(%)

Mosaic
(%)

Abnormal Nuclear
Morphology (%)

Other
(%)

Total No,
of Embryos

Mature

0(0)

3/15(20)

9/15(60)

3/15(20)

15

Immature

0(0)

0(0)

7/11(64)

4/11(36)

11
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TABLE 5.

Group

Oocyte Maturity and Embryo Classification For Embryos With 4 or More Blastomeres

Normal
(%)

Mosaic
(%)

Abnormal Nuclear
Morphology(%)

Other
(%)

Total No.
of Embryos

Mature

15/50 (30)a

19/50(38)

14/50(28)b

2/50(4)

50

Immature

2/50 (4)a

14/50(28)

32/50 (64)b

2/50(4)

50

a p = .0009
b p = .0006

6
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between stimulation protocol and embryo classification (p = 0.0057).

F. Lymphocyte Controls
Of the 300 lymphocyte nuclei scored, 297 contained one signal for
chromosome X (99%), and the remaining 3 nuclei contained no signal for X
(1%); 293 nuclei contained one signal for chromosome Y (98%), 4 contained no
signal for Y (1%) and 3 contained 2 signals for Y (1%); 286 nuclei contained
two signals for chromosome 18 (95%), 9 contained only one signal for 18 (3%),
and 5 contained 3 signals for 18 (2%).

G. Efficiency of the FISH Procedure
In the Mature group, 7/331 (2%) blastomeres were lost during the
fixation procedure, and 2/324 (0.6%) nuclei were either covered with cytoplasm
or without clear signals following the FISH procedure. In the Immature group,
4/342 (1.2%) were lost during the fixation procedure, and 5/338 (1.5%) nuclei
were either covered with cytoplasm or without clear signals following FISH.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

45

V.

DISCUSSION

In the present study, FISH analysis using ONA probes specific for
chromosomes X.Y, and 18 was used to compare 61 embryos derived from
Prophase I oocytes to 65 embryos derived from Metaphase I or II oocytes. We
report that only 2 (3%) of the embryos in the Immature group were normal.
This was significantly lower (p = 0.0012) than the percentage of normal
embryos in the Mature group (23%, Table 3). An embryo was considered
normal when all of the analyzed blastomeres contained a single nucleus with
the same normal diploid complement.
The percentage of embryos classified as having abnormal nuclear
morphology was significantly higher (p = 0.0014) in the Im m ature group (62%)
than in the Mature group (34%). As defined in the Methods section, embryos
in which 50% or more of the blastomeres were either multinucleated or
contained a fragmented nucleus were classified as having abnormal nuclear
morphology. Since the incidence of multinucleated blastomeres was the same
in the two groups (13% vs 11% in the Matures and Im m atures respectively),
a difference in the incidence of blastomeres with a fragmented nucleus was
responsible for this observed difference between the groups. Indeed a greater
percentage of blastomeres in the Immature group (19%) contained a
fragmented nucleus compared to their counterparts in the M atu re group (3%, p
<0.0001, Table 2).
In a study of 1145 blastomeres from 147 normally fertilized human
preimplantation embryos, Hardy et al. (1993) reported that 28 (2.4%) contained
a fragmented nucleus. Although the nuclear status at aspiration of the oocytes
from which these embryos were derived was not specifically mentioned, it can
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be assumed that they were mature since insemination occurred the day of
aspiration and fertilization assessment the following day. The investigators
speculated that fragmented nuclei represent a form of cell death similar to
apoptosis, with further degradation of the DNA fragments resulting in anuclear
blastomeres. Interestingly, we report that the percentage of anuclear
blastomeres was also significantly higher in the Immature group than in the
Mature group (33% vs. 25% respectively).
Juriscova and coinvestigators (1996) published a study in which they
used combined nuclear and terminal transferase-mediated DNA end labeling
(TUNEL) to detect signs of DNA fragmentation compatible with programmed cell
death (PCD) via apoptosis in arrested human preimplantation embryos. One of
the characteristics of cell death via apoptosis, as opposed to necrosis, is DNA
degradation into oligonucleosomal fragments which can be demonstrated by
the appearance of DNA “laddering” on agarose gel electrophoresis. The small
number of blastomeres in preimplantation embryos renders gel electrophoresis
impractical. However, an in situ technique utilizing TUNEL (Gavrieli et al.,
1991), allowed the authors to demonstrate extensive DNA fragmentation in the
nuclei of blastomeres from arrested human embryos. They concluded that PCD
with subsequent apoptosis may be responsible for the extensive fragmentation
observed in human embryos cultured in vitro, ultimately leading to cleavage
arrest. True PCD is genetically programmed, requiring activation of specific
genes for execution. The genes responsible, as well as the “trigger” which
activates them in human embryos, remain to be identified. In the present
study, nuclear fragmentation was much more prevalent among disaggregated
blastomeres in the Immature group than in the Mature group. Sixty-four
percent of the embryos in the Im m ature group had one or more blastomeres
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with a fragmented nucleus compared to 11% of embryos in the Mature group.
Of 11 blastomeres in the M ature group in which a fragmented nucleus was
observed, 4 were from the same embryo, and represented all of the cells from
that embryo. The remaining 7 cells were from 6 embryos, all of which
demonstrated abnormal nuclear morphology.
Apoptosis has also been implicated in the process of follicular atresia in
avian as well as mammalian species (Tilly et al., 1991). Using DNA analysis by
either ethidium bromide staining or 3’-end labeling followed by
autoradiography, the investigators demonstrated the presence of DNA
fragments characteristic of apoptosis in atretic but not normal, healthy follicles
obtained from chicken and porcine ovaries. We speculate that Prophase I
oocytes obtained following COH may come from follicles that have already
begun the process of atresia, the effect of which is profound on the oocyte
within. Indeed the fact that these follicles are large enough to be identified and
punctured at aspiration suggests at least a limited exposure and response to
the gonadotropins used for stimulation. Although these follicles were ‘‘selected”
by the ovary for inclusion into the “cohort” of developing follicles, their oocytes
failed to respond completely with a resumption of meiosis. Despite the fact that
some of these oocytes are able to mature upon removal from the follicle, and to
fertilize and sustain apparently normal development following insemination,
perhaps their fate, to become one of several million oocytes destined for atresia,
has already been sealed.
It is well known that early embryogenesis is dependent upon and
directed by macromolecules and organelles synthesized during the final stages
of oocyte growth and maturation (Telford et al., 1990; Wassarman and Kinloch,
1992). In particular, maternally-derived messenger RNA transcripts (mRNA)
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vital in supporting early cleavage divisions of the embryo are detectable
through the 4-6 cell stage in the human embryo (Heikenheimo et al., 1995).
Activation of the embryonic genome, the timing of which varies among species,
is thought to occur at the 4-6 cell stage in the human embryo as well (Braude et
al., 1988), thus marking the commencement of embryonic transcription. In a
study performed at the Jones Institute (Heikenheimo et al., 1996), levels of
maternally-inherited mRNA transcripts for c-mos kinase and cyclin -B1, two
proteins involved in the up-regulation of maturation promoting factor (MPF)
activity, were not significantly different in Prophase I oocytes and Metaphase II
oocytes before or after in vitro culture. The authors concluded that the reduced
developmental potential of embryos derived from Prophase I oocytes may not
be attributable to extensive degradation of these transcripts during culture or to
reduced levels of their respective gene products early in development. These
data can be used to further the theory outlined above, namely that Prophase I
oocytes from stimulated ovaries are aspirated from follicles that have begun the
process of atresia. Perhaps a cytoplasmic factor synthesized at or shortly after
the onset of follicular atresia remains stable through oocyte maturation,
fertilization and early development, eventually activating genes responsible for
the execution of cell death via apoptosis, observed as DNA fragmentation in the
present study.
We acknowledge that the method used in the present study is not the
most sensitive available for the detection of DNA degradation compatible with
PCD and subsequent apoptosis. The in situ technique utilizing TUNEL
described by Gavrieli and coworkers (1991) would have been preferable.
However, the finding that blastomeres containing a fragmented nucleus are
prevalent among embryos derived from Prophase I oocytes was not
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anticipated. Indeed, we expected to find a higher incidence of aneuploidy
and/or mosaicism in embryos derived from Prophase I oocytes compared to
their counterparts derived from Metaphase I or II oocytes. Although it would
have been best if the nuclear fragmentation could have been documented in
the intact blastomere before fixation, helping to rule out the possibility that the
observed fragmentation was a procedural artifact, it is notable that in the vast
majority of blastomeres found to contain a fragmented nucleus, a distinct,
membrane-bound nucleus was not visible under the inverted microscope
before the fixation procedure. Rather, a “suspicious”, lightened area was
present within the cytoplasm. We did not recognize the nuclear fragments as
such until the FISH procedure was performed. Perhaps improved microscope
optics would have allowed us to observe the fragmentation in the intact
blastomere. We acknowledge that additional investigation is required to clarify
this issue.
In the study mentioned briefly above, Hardy et al. (1993) used Hoechst
33342, a polynucleotide-specific fluorochrome, to label the nuclei of
disaggregated blastomeres from human preimplantation embryos. In addition
to the blastomeres with fragmented nuclei, the investigators noted the presence
of blastomeres with other nuclear abnormalities. The most common of these
abnormalities, binucleate blastomeres, occurred in 17% of normally fertilized
embryos at the 2-4 cell stage and in 65% of those at the 9-16 cell stage.
Although various mechanisms have been implicated in the formation of
binucleate blastomeres, including cell fusion, nuclear amitotic splitting, and
acytokinesis, estimates of blastomere volume based on cell diameter and
measurements of nuclear size in their study led the authors to speculate that
binucleate blastomeres in human embryos most often arise through a failure of
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cytokinesis between the second and fourth cleavage divisions.
In the present study, there was no difference in the incidence
of multinucleated blastomeres between the groups. Forty-nine percent and
44% of embryos in the Mature and Im m ature groups respectively contained
one or more multinucleated blastomeres. In addition, 13% and 11% of the
disaggregated blastomeres in the Mature and Immature groups respectively
were multinucleated. In the Mature group, 80% of these were binucleate
compared to 63% in the Immature group. Our analysis of binucleate
blastomeres suggests that at least two of the mechanisms mentioned above,
acytokinesis and nuclear amitotic splitting, contribute to the formation of
binucleate blastomeres in human embryos. We observed binucleated
blastomeres in which each nucleus contained the same number of signals for
chromosomes X, Y, and 18 as sibling mononucleated cells, and others in which
the sum of the signals in the two nuclei was the same as that observed in sibling
mononucleated cells. However, the number and distribution of chromosomes in
the nuclei of binucleate blastomeres varied greatly, suggesting that other
mechanisms may be involved as well. Our results are comparable to that
reported by Munne and coworkers (1993) who found that 11.5% of blastomeres
from arrested human embryos and 27.6% of blastomeres from normally
developing human embryos were multinucleated. They also reported that a
vast majority (79.6%) of the multinucleated blastomeres contained two nuclei.
Another abnormality observed in preimplantation embryos is the
presence of anuclear blastomeres. Munne et al. (1993) reported the incidence
of anuclear blastomeres in human embryos as follows: 24.8% of blastomeres in
arrested embryos; 11% of blastomeres in slow and/or fragmented embryos; and
4.4% of blastomeres in normally developing embryos. In the present study,
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25% of the disaggregated blastomeres in the M ature group were anuclear and
33% of their counterparts in the Immature group were anuclear. One possible
explanation for the higher incidence of anuclear blastomeres in the study
reported here is that all blastomeres, even those without a visible nucleus under
the inverted microscope, were fixed and recorded. Some of these may have
been cytoplasmic fragments. In later stages of development (8-12 cells), it is
difficult to distinguish an anuclear blastomere from a cytoplasmic fragment.
Nuclear abnormalities in blastomeres of human embryos obtained by IVF
contribute to developmental arrest, and may explain, in part the low
implantation and pregnancy rates realized following embryo transfer. Clearly,
anuclear blastomeres and those with a fragmented nucleus lack the potential
for further development. Although the exact mechanisms responsible for the
formation of blastomeres with nuclear abnormalities in IVF-generated embryos
remain uncertain, it has been suggested that the the culture conditions routinely
used, likely to be sub-optimal, contribute (Hardy et al., 1993).
The incidence of mosaicism in human embryos may also be related to in
vitro culture conditions. Mosaicism is defined as the presence of two or more
different cell lines within a single embryo. In a study in which normally
developing human embryos obtained from four IVF centers were evaluated
using FISH with DNA probes specific for chromosomes X,Y, 13,18, and 21,
Munne and coinvestigators (1997) found that the rate of mosaicism differed
greatly between the centers, ranging from 11% in one center to 52% in another.
They concluded that in vitro culture conditions and/or hormonal stimulation
protocols may affect the incidence of mosaicism in the resulting embryos,
perhaps explaining in part, the differences in success rates between IVF
centers. In the study reported here, 34% of embryos in the Mature group were
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mosaic compared to 23% in the immature group. This difference was not
statistically significant, perhaps due to the fact that the embryos in both groups
were cultured under identical conditions. As outlined in the Methods section,
embryos with one or more multinucleated blastomeres and/or blastomeres with
a fragmented nucleus were automatically classified as mosaic. We
acknowledge that this classification system may result in an overestimation of
the incidence of chromosomal mosaicism in preimplantation embryos. In an
attempt to address this issue, we reevaluated all of the mosaic embryos in each
group considering only those blastomeres with a single nucleus (i.e.
disregarding multinucleated blastomeres and blastomeres with a fragmented
nucleus). Considering mononucleated blastomeres only, 7 of the mosaic
embryos in the Mature group and one of the mosaic embryos in the Im m ature
group would be classified as normal, changing the incidence of mosaicism in
the M ature group from 34% to 23%, and in the Immature group, from 23% to
21%. Although this difference is still not statistically significant, it did make the
difference in the incidence of normal embryos in the two groups more apparent
(34% in the Mature group vs. 5% in the Immature group).
The occurrence of mosaicism in human embryos is of great interest
because it has profound implications on the relatively new field of
preimplantation genetic diagnosis. Embryo biopsy, the removal of one or two
blastomeres from a preimplantation embryo for the purpose of genetic analysis,
could lead to misdiagnosis in the case of a mosaic embryo. It has been
suggested that there is a mechanism which diverts abnormal cells to the
trophectoderm, thereby selecting against them during embryonic development
(James and West, 1994). In this way, chromosomally abnormal cells are
prevented from participation in the formation of the embryo proper. Whether or
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not mosaicism occurs in normally conceived human embryos remains
uncertain.
We also investigated the incidence of aneuploidy for chromosomes X,Y,
and 18 in the two groups of embryos. Aneuploidy, defined as a chromosomal
constitution different from the normal diploid constitution by loss or duplication
of one or more chromosomes or chromosome segments, was found to be low in
both the Mature (0%) and Immature (3%) groups. This is in contrast to a rate
of 5.3% reported by Munne et al. (1995). There are several possible
explanations for this discrepancy between the two studies. First, the average
age of patients in the study presented here was quite low, 35.5 +/- 2.7 years and
28.0 +/- 3.8 years in the Mature and Immature groups respectively. While our
data includes only one embryo from a patient over 38 years of age, more than a
third of the embryos in Munne's study were from patients 40 years of age or
older. In addition, although Munne reported a significant increase in
aneuploidy with maternal age, this increase was mostly due to an increase in
aneuploidy for chromosomes 13 and 21. Indeed the trend toward increasing
aneuploidy for gonosomes and chromosome 18 in his study, which began only
after 40 years of age, did not reach statistical significance. Lastly, according to
Munne’s classification system, embryos are both mosaic and aneupioid when
the average of their cells, corrected for errors in ploidy, are aneupioid for a
specific chromosome. In the present study, such embryos were classified as
mosaic only.
Although an ideal study designed to evaluate the effect of oocyte maturity
at aspiration on embryo classification would evaluate embryos derived from the
different types of oocytes obtained from the same patients, the realities of
human reproduction make this impractical. We feel justified in comparing
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embryos in the M ature and Im m ature groups, because evaluation of various
IVF parameters in the patients from which they came suggests a similar
response to stimulation (Table I). With the exception of the fertilization rate,
which was significantly lower in the Immature group, there were no differences
between the groups. Note that information on fertilization, transfer, and
pregnancy outcome for oocyte donors in the Immature group pertain to the
mature oocytes received by their recipient(s). With this in mind, one possible
explanation for the lower fertilization rate in the Im m ature group is an
unsuspected male factor infertility in the oocyte recipient couple. Indeed there
were several cases in which fertilization was poor, including one in which of 23
mature oocytes donated to a single recipient, only 5 fertilized normally.
A total of 176 Prophase I oocytes were donated for this study, and
following insemination, 45% fertilized as evidenced by the presence of two
pronuclei. This fertilization rate was low compared to the 80% previously
published (Veeck, 1984), but may may be due in part to the fact that some of the
inseminated oocytes were arrested at the germinal vesicle stage. In order to
reduce the amount of extra work required for this study, many Prophase I
oocytes were inseminated the day after aspiration without assessing their
nuclear status, including some that had failed to undergo germinal vesicle
breakdown. In addition, we evaluated more recent data from the clinical
laboratory on the fate of Prophase I oocytes collected from January of 1995 to
March of 1996 (Series 58-62) and found that 46% of the Prophase I oocytes
aspirated matured in vitro, and of those that were inseminated, 60% fertilized
(unpublished data, Jones Institute database).
In the study reported here, we were unable to detect a correlation
between patient age and embryo classification in either the Mature or
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Immature group. This may be due to the fact that the embryos we analyzed

were from relatively young patients. This is especially true of the oocyte donors
in the Immature group. Such a correlation is likely to become more apparent
in embryos from older patients. In the M ature group, there was no significant
relationship between stimulation protocol and embryo classification or type of
infertility and embryo classification. If these correlations exist, detection may
require analysis of a larger group of embryos.
We acknowledge several differences in the two groups of embryos in our
study which may have contributed to the results we observed. For example, all
of the embryos in the M ature group were cryopreserved and subsequently
thawed before analysis. In contrast, all but 7 of the embryos in the Immature
group were fresh. In addition, embryos in the Immature group, by virtue of the
fact that they were derived from Prophase I oocytes which required a 24-36
hour incubation period to complete nuclear maturation before insemination,
were in culture one day longer than embryos in the M ature group. It is
possible that this extra day in culture conferred instability to the nuclear
membrane in blastomeres from these embryos, observed as nuclear
fragmentation in our study. If so, perhaps a change in culture conditions would
correct this problem. Indeed, Lanzendorf and coworkers (1996) demonstrated
that embryos derived from Prophase I oocytes differ in culture requirements
than embryos derived from Metaphase I or II oocytes in the cynomolgus
monkey.
We also caution that our findings may not apply to ail Prophase I oocytes
obtained following COH. In a study performed at the Jones Institute, Moffitt and
coinvestigators (1993) found that Prophase I oocytes from large cohorts and
cohorts with a greater percentage of Prophase I oocytes may have a greater
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developmental potential than those from smaller cohorts and cohorts with a
greater percentage of Metaphase I and II oocytes.
In summary, the present findings suggest that few embryos derived from
Prophase I oocytes are normal, perhaps explaining in part why they rarely
establish pregnancies in our IVF program. Comparison of the incidence of
nuclear abnormalities observed in blastomeres in the two groups revealed that,
although there was no difference in the incidence of multinucleated
blastomeres, embryos derived from Prophase I oocytes had a significantly
higher incidence of both anuclear blastomeres and blastomeres with a
fragmented nucleus than their counterparts derived from mature oocytes.
Because nuclear fragmentation is a hallmark of programmed cell death via
apoptosis, which has been implicated in the processes of follicular atresia in
vivo and cleavage arrest iv vitro, we speculate that Prophase I oocytes obtained
following COH originate from follicles in early stages of atresia.
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APPENDIX A

Ultrastructural and Molecular Evaluation of Preembryos Resulting from
Immature Human Oocytes

The following protocol (Appendix A1) and consent forms (Appendices A2
and A3) were submitted to and approved by the Institutional Review Board of
Eastern Virginia Medical School on September 27, 1994. The consent form in
A2 was used to obtain immature oocytes. The consent form in A3 was used to
obtain semen for the insemination of donated oocytes. These forms were
distributed and the nature of the study explained to all donors. Information
concerning donor identity was kept confidential.
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APPENDIX A1

ULTRASTRUCTURAL AND MOLECULAR EVALUATION OF PREEMBRYOS
RESULTING FROM IMMATURE HUMAN OOCYTES

Background
Before ovulation, the human oocyte, located within the follicle of the
ovary, is immature and cannot be fertilized. The nucleus of the immature oocyte,
defined as the germinal vesicle (GV), contains chromosomes arrested at the
prophase I stage of meiosis. This arrest must be overcome and meiosis must
continue before the oocyte can support the development initiated by a
penetrating spermatozoon. While arrested, the oocyte increases in size and
develops associated cells (granulosa and theca cells) and membranes.
Appropriate hormonal stimulation at the time of ovulation initiates cytoplasmic
and nuclear maturation. The nuclear membrane disappears and the nucleus
completes the first meiotic division. The progression of the oocyte to the
metaphase II (M il) stage of development confers "fertilizability" to the oocyte,
allowing it to take part in sperm incorporation, the cortical reaction, and
decondensation of sperm chromatin.
In vitro fertilization (IVF) protocols routinely utilize exogenous hormonal
stimulation to increase the number and growth of ovarian follicles. As a result of
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the complexities of folliculogenesis, even in spite of adequate stimulation,
oocytes retrieved will vary in maturational stage (Testart et al., 1983; Veeck,
1986). Mature preovulatory oocytes are typically inseminated soon after
collection and, in humans and monkeys, demonstrate the highest rate of
fertilization and pregnancy following transfer.
Oocytes deemed immature at the time of recovery may be cultured in
vitro, allowing for the completion of nuclear maturation. However, these in vitro
matured oocytes demonstrate low rates of fertilization and pregnancy (Testart et
al., 1983, Veeck, 1986, 1989; Lanzendorf et al., 1990). Therefore, the stage of
oocyte maturity at collection plays a large part in IVF outcome, and
hyperstimulation protocols are used which provide the greatest number of
mature oocytes.
Gene Expression in the Maturing Oocvte
In the early 1970s it was discovered that cytoplasm of the mature frog
oocyte activated meiosis and maturation when injected into the immature oocyte.
This activating agent was termed maturation promoting factor (MPF) and was
found to be contained in the mitotic cells of all eukaryotes tested including the
human. Following its purification, MPF was found to be a high-molecular-weight
protein with protein kinase activity. Studies performed in the sea urchin
uncovered a protein referred to as cyclin, which accumulated in dividing cells in
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a cyclic fashion, disappearing at the m et^ihase-an^hase transition In a series
of experiments, cycfin was found to cause cell division. F irth e r studies indicated
cydin easts in a protein complex with protein kinase activity and that this
complex is MPF (Draetta ef al.. 1989).
The cellular counterpart of a viral proto-oncogene, c-mos has been shown
to phosphorylate cydin. In the mouse, expression of c-mos is restricted to a few
tissues, such as the ovary and testis (Propst & Vande Woude. 1985). In situ
hybridization studies also suggest that c-mos is expressed in developing
oocytes of the mouse (Goldman et al., 1987). During meiotic maturation to
metaphase II, the level of c-mos transcripts decrease by approximately 20%
(Mutter et ai, 1988). This level of transcripts continues to fall after fertilization
and is undetectable from the 2-cell to blastocyst stage (Goldman et a i. 1988).
In the mouse, lactate dehydrogenase (LDH) activity is found at very high levels
in grown oocytes. The synthesis of LDH accounts for as much as 1.8% of total
protein synthesis during oocyte growth and has been shown to decrease 7 and
20-fold during meiotic maturation and fertilization, respedively (Cascio &
Wassarman, 1982). The steady-state level of this energy metabolism gene
decreases by only 20% during meiotic maturation, however, LDH synthesis falls
7-fold. Similar patterns of synthesis and mRNA levels during meiotic maturation
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are seen with beta-actin and are attributed to deadenylation (Bachvarova eta!.,
1985; Paynton eta!., 1988)
Hormonal Supplementation of Culture Medium
Studies to improve in vitro maturation using media supplementation with
gonadotropic hormones, such as follicle-stimulating hormone (FSH) and/or
luteinizing hormone (LH), have been performed using many species, including
the mouse, cat, cow, rhesus monkey and human (Jagiello eta/., 1975; Shea et
al., 1975; Prins et al., 1987). The majority of these studies have demonstrated
an increase in maturation, fertilization and cleavage rates. However, despite
some limited success, adequate controlled studies have not been performed in
the human.
Jagiello and coworkers (1975) studied the effects of hormone additives on the
maturation of human oocytes, in a limited study where sizes were small.
Additives such as LH, estradiol, human chorionic gonadotropin (hCG), cyclic
AMP, prostaglandins E1 and E2, and prolactin were investigated; only LH,
estradiol and cyclic AMP were found to be beneficial. In another study, Shea
and investigators (1975) added progesterone to culture medium and found no
significant effect on germinal vesicle breakdown or on the number of oocytes
which matured to Mil. Prins and coworkers (1987) cultured immature oocytes in
medium supplemented with LH and FSH and demonstrated a significant
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increase in the rate of maturation and fertilization compared to control oocytes.
No conclusions were made on later development in vivo with these studies.
Coculture of Oocvtes and Preembrvos
In recent years, investigators have utilized coculture techniques to
enhance the in vitro environment of gametes and preembryos. Coculture
typically involves the production of an anchorage dependent cell culture (feeder
cells), such as epithelial cells, upon which another cell type is grown. An
increase in fertilization rates has been demonstrated in bovine and human
(Dandekar et al., 1991) oocytes following their maturation on granulosa cell
cultures obtained from mature, preovulatory follicles. Therefore, the presence of
granulosa cells during maturation may induce or assist in nuclear and/or
cytoplasmic maturation in vitro.
Investigators have also demonstrated an increase in cleavage and
implantation when bovine preembryos, derived from oocytes matured in vitro,
were cultured with feeder cells (Eyestone & First, 1989; Wiemer et al., 1991). It
is believed that oviductal cells may secrete certain factors which are beneficial to
the developing preembryo and provide an environment similar to that in vivo
(Gondolfi eta!., 1989).
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Specific Aims
The goal of the work proposed is to investigate mechanisms for the
decreased developmental potential of human oocytes matured in vitro. In
addition, studies will be performed to optimize rates of in vitro maturation,
fertilization and cleavage in vitro. The specific aims of this study are:
1.

To demonstrate that in vitro matured oocytes and resulting
preembryos exhibit decreased levels in the expression of genes
important for cell cycle control and energy metabolism. Levels of
c-mos, cyclin, actin, and LDH will be determined in immature, in
vitro matured and in vivo matured human oocytes, as well as
embryos resulting from in vivo and in vitro matured oocytes.

2.

To demonstrate that supplementation of culture with
gonadotropins, growth factors and feeder cells enhances the rate
of in vitro maturation and fertilization, and results in development
comparable to that achieved by in vivo matured oocytes.
Experimental endpoints will include both ultrastructural, molecular
and biochemical analysis of oocytes and preembryos.

Preliminary Data
Preliminary investigations have begun to study the expression pattern of
c-mos in the multiple tissues of the cynomolgus monkey and single oocytes of
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the monkey and human (Heikinheimo etal., in preparation). Using amplification
of cDNA reverse transcribed from RNA (RT-PCR), expression of c-mos could be
detected in monkey ovary, testis, pituitary and hypothalamus. Lung, spleen,
adrenal, kidney and muscle did not reveal any c-mos expression. RT-PCR
amplification of ft-actin, a house-keeping gene, was used as a reference and
internal control in the experiments. Equal intensity of the PCR amplified 13-actin
suggested that approximately equal quantities of starting mRNA was used. In
addition to the expected size, the identity of the PCR product was verified by
Southem-hybridization analysis of the amplified DNA fragment using
oligonucleotide probes internal to the PCR primers. As previously demonstrated
in the mouse model, we found strong expression of c-mos also detected in
single monkey and human oocytes. However, no c-mos mRNA could be
detected in granulosa ceils alone. From these findings, we conclude that c-mos
is an important, highly oocyte specific maturation factor present in the primate
oocyte.
Studies are also planned for the evaluation of cyclin B1 in human oocytes
and early preembryos. We currently have the cyclin B1 primers and have
successfully amplified cyclin mRNA in as few as two monkey oocytes.
Basic research studies involving the improvement of immature oocyte
potential has been performed in the monkey model. The monkey model allows
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us the unique opportunity to compare the developmental potential of embryos
resulting from immature oocytes to that of mature oocytes from the same animal.
We have established a protocol for obtaining immature, germinal vesicle-intact
oocytes from one ovary of hyperstimulated cynomolgus monkeys by
iaparoscopic aspiration 16 hours after hCG administration. At 34 hours after
hCG, another aspiration is performed and mature oocytes are collected from the
other ovary. In vitro and in vivo matured oocytes are inseminated at the same
time using the same sperm sample and fertilization and cleavage rates are
evaluated and compared between the two groups. Using this protocol, we have
investigated the beneficial effect of feeder cells on the development of
preembryos resulting from immature oocytes. While the data show no significant
benefit to embryos resulting from mature, metaphase II oocytes, only those
preembryos from immature oocytes cocultured with feeder cells reached the
expanded blastocyst stage (75%) compared to 0% cultured in medium alone.
These results suggest that coculture may enhance in vitro development of
embryos resulting from immature oocytes.
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Experimental Design
Specific Aim 1. To determine if in vitro matured oocytes and
resulting preembryos exhibit decreased levels in the expression of genes
important for cell cycle control and energy metabolism. Levels of c-mos,
cyclin, actin, and LDH will be determined in immature and in vitro matured
oocytes, as well as preembryos resulting from in vivo and in vitro matured
oocytes.

For this study, RT-PCR techniques will be utilized to measure
quantitatively the expression of these cell cycle control and energy metabolism
genes in human oocytes and preembryos. The levels of expression in immature
oocytes will be compared to those found in in vitro matured and in vivo matured
oocytes. It is expected that levels of expression in in vitro mature oocytes will be
significantly lower than those of in vivo matured oocytes. The expression of
these genes will also be documented in the fertilized oocytes as well as cleaving
preembryo to determine at what cell stage their expression is turned off, and if
preembryos resulting from in vitro matured oocytes are deficient in levels of
these genes.
2.

To determine if supplementation of culture medium with

gonadotropins, growth factors and feeder cells enhances the rate of in
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vitro maturation and fertilization, and results in development comparable to
that achieved by in vivo matured oocytes. Experimental endpoints will
include both ultrastructural, molecular and biochemical analysis of oocytes
and preembryos.

Immature oocytes will be cultured in medium supplemented with
gonadotropins and/or growth factors. Controls will consist of oocytes cultured
without these supplementations. Differences in rates of maturation, fertilization
and cleavage between treatment and control groups, and fertilization and
cleavage between treatment groups, controls, and in vivo matured oocytes will
be recorded for statistical comparison. In addition, resulting preembryos will be
divided and examined using the following techniques:
A.

Ultrastructural evaluation - electron and immunofluorescent
microscopy will be utilized to examine ultrastructure and cell
numbers in test and control preembryos. In addition, preembryos
will be examined for genetic abnormalities using karyotypic
analysis.

B.

Biochemical evaluation - hCG production of cultured preembryos
will be performed on culture media using RIA techniques and
compared in test and control preembryos.
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C.

Molecular evaluation - preembryos included in this specific aim will
be evaluated for DNA and mRNA expression using PCR and RTPCR technology.

Specific Aim 2 will also examine the supplementation of culture with
feeder cells. Maturing oocytes will be cocultured in wells seeded with granulosa
cells collected from the patient's own follicles at aspiration. Maturation rates will
be compared to control oocytes cultured in medium only. Comparisons will be
made between rates of maturation, fertilization, and development between
treated, control, and oocytes matured in vivo. The effects of coculture in the
presence of exogenous gonadotropins as well as the appropriate time for
removal of the oocytes from the granulosa cell environment will also be
determined. Preembryos resulting from oocytes matured in vitro will be cultured
with feeder cells and development compared to control preembryos and
preembryos developing from oocytes matured in vivo. Oocytes used in this
study will include those resulting from the previous experiment (treated and
controls) to demonstrate an additive effect by both coculture treatments. In
addition, resulting preembryos will undergo further evaluation with
ultrastructural, biochemical and molecular techniques as described on page 9.
For both specific aims, successful experimental outcome will be achieved
when the in vitro results are statistically comparable to earlier results obtained
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with in vivo matured oocytes. In addition, procedures with successful outcomes
will be utilized together to determine if combining protocols will produce
maximum success.
For this study, oocytes will be fertilized using one of two methods:
1.

the addition of husband's sperm to the culture dish containing the
oocyte(s); or

2.

fertilization by intracytoplasmic sperm injection (ICSI).

ICSI is currently used clinically to fertilize oocytes for infertile couples.
This technique, which involves direct injection of a single sperm into the egg,
has proved to be very efficient in the fertilization of human oocytes.
Consents
For this study, human preembryos resulting from in vitro and in vivo
matured oocytes will be examined. Evaluation of the preembryos will render
them nonviable, therefore, they will not be used for initiation of pregnancy.
Two groups of preembryos will be examined: (1) those resulting from in
vitro matured oocytes (immature at aspiration); and (2) in vivo matured oocytes
(mature at aspiration). Patients donating the in vitro matured oocytes will be
consenting to their fertilization with husband's sperm and then use in an assay
which will render the preembryos nonviable (proposed consent attached).
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The second group of preembryos will be donated by patients who no
longer wish their frozen preembryos to be stored by cryopreservation. These
preembryos will include those resulting from both immature and mature oocytes.
At the patients request, they will be sent a form entitled "Authorization for
Utilization of Cryopreserved Pre-zygote(s) at the Jones Institute" (see copy
included). One option that the couple may choose is the use of the stored pre
zygotes for approved research. It is that approval we are requesting in this
protocol.
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APPENDIX A2

Medical College of Hampton Roads
Approval Date: September 27, 1994
IRB # 07-08-93-0043
Revision Date: August 2, 1995
Re-Approved: August 22, 1995
SUBJECT CONSENT FORM
TITLE: Ultrastructural and Molecular Evaluation of Preembryos Resulting from
Immature Human Oocytes
INVESTIGATORS: Susan Lanzendorf, Ph.D., Suheil J. Muasher, M.D., William E.
Gibbons, M.D., and Jacob F. Mayer, Ph.D.
TELEPHONE: (804) 446-8948 which answers 24 hours a day in case of questions or
problems.
SOURCE OF SUPPORT: The Jones Institute for Reproductive Medicine
DESCRIPTION: I am being asked to participate voluntarily in this research study, the
purpose of which is to investigate the developmental potential of immature (Prophase I)
oocytes (eggs). I understand that many patients have a number of Prophase I eggs.
These immature eggs can often be matured in the laboratory and may sometimes
undergo fertilization and early division. Nonetheless, they do not have an equal
potential to develop into pregnancies as do eggs recovered in a mature state.
The main purpose of this study is to investigate methods to improve the developmental
capacity of immature human oocytes. As a participant in this study, I am being asked
to donate immature (germinal vesicle-bearing) eggs which I do not require for transfer
as a patient undergoing an in vitro fertilization (IVF) attempt through the IVF program
at the Medical College of Hampton Roads (MCHR).
1 understand that the egg(s) which I donate will be immature and will be matured in
vitro, using standard maturation techniques employed by the Jones Institute. These
immature eggs can often be matured in the laboratory and may sometimes undergo
fertilization and early division. Once matured, all the eggs will be inseminated by my
husband’s sperm and allowed to develop in vitro to determine whether or not they are
capable of development. During development, preembryos resulting from the
immature oocytes will be evaluated using techniques which will render the
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non-viable. At no time will resulting preembryos be used to initiate a
pregnancy in myself or anyone else.
p r e e m b r y o (s )

EXCLUSION CRITERIA: I understand that I am being asked to donate immature
eggs only in the event that I have no history of fertilization failure, [f on the day of
aspiration, I have six (6) or more mature eggs, my immature eggs may be used for this
protocol.
RISKS: There are no known risks to me at this time; however, there may be risks not
yet identified.
BENEFITS: I understand that the pregnancy potential of immature eggs is very low
and that preembryos resulting from this study will probably not increase my chances of
achieving a pregnancy. However, much information can be gained from this study,
which may enable investigators to improve the limited functional capacity of immature
eggs to produce pregnancy. Scientific information from this study may have
widespread application for future IVF cycles.
ALTERNATIVE TREATMENT: 1 have been informed that the only known
alternative treatment is not to participate in this study.
COSTS AND PAYMENTS: 1 understand that there is no additional cost to me for
participating in this research project, including the cost of future intrauterine
replacement o f preembryos obtained during this cycle. I further understand that I will
receive no reimbursement for my participation in this study.
NEW INFORMATION: I understand that any new information obtained during the
course of the research that may affect my willingness to continue participation in this
study will be provided to me or to my legal representative.
CONFIDENTIALITY: I understand that any information concerning me which is
derived from this study will be kept confidential, including answers to questionnaires,
history, laboratory data findings, or physical examination(s) will be kept strictly
confidential, and that my records will be protected within the limits o f the law.
I also understand that the data derived from this study could be used in reports,
presentations or publications, but that I will not be individually identified. I understand
that, in order to ensure that Food and Drug Administration (FDA) regulations are being
followed, it may be necessary for a representative of the FDA to review my medical
records. FREE WITHDRAWAL: 1 understand that I am free to refuse to participate
in this study or to withdraw at any time and that my decision will not adversely affect
my care at this institution or cause a loss of benefits to which 1 might be otherwise
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entitled. If I do decide to withdraw, I agree to undergo all trial evaluations necessary
for my safety and well-being, as determined by my physician.
COMPENSATION FOR ILLNESS OR INJURY: I understand that in the unlikely
event of a physical injury or physical illness resulting from the research procedure, no
monetary compensation will be made, but any immediate emergency medical treatment
which may be necessary will be made available to me without charge by the
investigators. I am advised that if any injury should result from my participation in this
research project, Medical College o f Hampton Roads (MCHR) provides no
compensation plan or free medical care plan to compensate me for such injuries. In the
event I believe I have suffered injury as a result o f my participation in any research
program, I may contact Dr. Gerald Pepe, phone (804) 446-8423, an employee of
MCHR, who will be glad to review the matter with me.
VOLUNTARY CONSENT: I certify that I have read the preceding or it has been
read to me, that I understand its contents, and that any questions I have pertaining to
the research and my rights as a research subject have been answered by Susan
Lanzendorf, Ph.D., Suheil J. Muasher, M.D., William E. Gibbons, M.D., or Jacob F.
Mayer, Ph.D., whose phone number (804) 446-8948. I have been given a copy of the
signed informed consent. My signature below means that 1 have freely agreed to
participate in this experimental study.

Wife’s signature

Date

Husband’s signature

Date

Witness' signature

Date

I certify that I have explained to the above individual the nature and purpose, the
potential benefits, and possible risks associated with participating in this research study,
have answered any questions that have been raised and have witnessed the above
signature. I have explained the above to the volunteer on the date stated on this consent
form.

Investigator’s signature

Date
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APPENDIX A3

Medical College of Hampton Roads
Approval Date: September 27, 1994
IRB if 07-08-93-0043
Revision Date: August 2, 1995
Addendum Approval Date: August 22, 1995

ADDENDUM TO SUBJECT CONSENT FORM
TITLE: Ultrastructural and Molecular Evaluation of Preembryos Resulting from
Immature Human Oocytes. II Semen Donors
INVESTIGATORS: Susan Lanzendorf, Ph.D., Mahmood Morshedi, Ph.D., Suheil J.
Muasher, M.D., William E. Gibbons, M.D., and Jacob F. Mayer, Ph.D.
TELEPHONE: (804) 446-8948 which answers 24 hours a day in case of questions or
problems.
SOURCE OF SUPPORT: The Jones Institute for Reproductive Medicine
DESCRIPTION: 1 am being asked to participate voluntarily in this research study, the
purpose of which is to investigate the developmental potential of immature (Prophase I)
oocytes (eggs). I understand that many in vitro fertilization patients have a number of
Prophase I eggs. These immature eggs can often be matured in the laboratory and may
sometimes undergo fertilization and early division. Nonetheless, they do not have an
equal potential to develop into pregnancies as do eggs recovered in a mature state.
The main purpose of this study is to investigate methods to improve the developmental
capacity of immature human oocytes. As a participant in this study, I am being asked
to consent to the use of my sperm (or aportion thereof) which has been previously
donated or will be donated in the future for the insemination of immature eggs for
research purposes.
1 understand that resulting preembryos will be evaluated using techniques which will
render the preembryo(s) non-viable. At no time will resulting preembryos be used to
initiate a pregnancy in anyone.
RISKS: There are no known risks to me at this time; however, there may be risks not
yet identified.
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BENEFITS: I understand that much information can be gained from this study, which
may enable investigators to improve the limited functional capacity of immature eggs to
produce pregnancy. Scientific information from this study may have widespread
application for future IVF cycles.
ALTERNATIVE TREATMENT: I have been informed that the only known
alternative treatment is not to participate in this study.
COSTS AND PAYMENTS: I understand that there is no cost to me for participating
in this research project. I also understand that, because I have been reimbursed for the
donation of my semen for initiation o f pregnancy, and the semen to be used for this
study is excess from my previous donation, I will therefore not be reimbursed for
consenting to the use my semen in this study.
NEW INFORMATION: I understand that any new information obtained during the
course of the research that may affect my willingness to continue participation in this
study will be provided to me or to my legal representative.
CONFIDENTIALITY: I understand that any information concerning me which is
derived from this study will be kept confidential, including answers to questionnaires,
history, laboratory data findings, or physical examination(s) will be kept strictly
confidential, and that my records will be protected within the limits of the law.
I also understand that the data derived from this study could be used in reports,
presentations or publications, but that 1 will not be individually identified. I understand
that, in order to ensure that Food and Drug Administration (FDA) regulations are being
followed, it may be necessary for a representative o f the FDA to review my medical
records.
FREE WITHDRAWAL: I understand that I am free to refuse to participate in this
study or to withdraw at any time and that my decision will not adversely affect my care
at this institution or cause a loss of benefits to which 1 might be otherwise entitled. If I
do decide to withdraw, I agree to undergo all trial evaluations necessary for my safety
and well-being, as determined by my physician.
COMPENSATION FOR ILLNESS OR INJURY: I understand that in the unlikely
event of a physical injury or physical illness resulting from the research procedure, no
monetary compensation will be made, but any immediate emergency medical treatment
which may be necessary will be made available to me without charge by the
investigators. 1 am advised that if any injury should result from my participation in this
research project, Medical College o f Hampton Roads (MCHR) provides no
compensation plan or free medical care plan to compensate me for such injuries. In the
event I believe I have suffered injury as a result of my participation in any research
program, I may contact Dr. Gerald Pepe, phone (804) 446-8423, an employee of
MCHR, who will be glad to review the matter with me.
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VOLUNTARY CONSENT: I certify that I have read the preceding or it has been
read to me, that I understand its contents, and that any questions I have pertaining to
the research and my rights as a research subject have been answered by Susan
Lanzendorf, Ph.D., Mahmood Morshedi, Ph.D., Suheil J. Muasher, M .D., William E.
Gibbons, M.D., or Jacob F. Mayer, Ph.D., whose phone number (804) 446-8948. I
have been given a copy o f the signed informed consent. My signature below means
that I have freely agreed to participate in this experimental study.

Donor's signature

Date

Witness' signature

Date

I certify that I have explained to the above individual the nature and purpose, the
potential benefits, and possible risks associated with participating in this research study,
have answered any questions that have been raised and have witnessed the above
signature. 1 have explained the above to the volunteer on the date stated on this consent
form.

Investigator’s signature

Date
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APPENDIX B

Authorization for Utilization or Disposition of Cryopreserved
Prezygote(s)/Preembryo(s) at the Jones Institute

Appendix B contains a form distributed to IVF patients of The Jones
Institute no longer wishing to keep their embryos in cryostorage. Under the
protocol mentioned above (Appendix A1), we were able to use embryos
donated for research in our study.
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AUTHORIZATION FOR UTILIZATION OR DISPOSITION OF
CRYOPRESERVED PREZVCQTEISVPREEMBRYOfS) AT THE JONES
INSTITUTE
We:___________________________________hereby forever irrevocably donate and
transfer to The Jones Institute all of ourjoint and several rights, titles, and interests in and to
our _ (number) fertilized human egg(s) - prezygote(s)/preembryo(s) which were frozen and
stored (cryopreserved) at The Jones Institute Cryopreservation Laboratory on
, in IVF
cycle number for the following purpose.

Instructions:
-Select below a single (ONE) option agreed to by both husband and wife.
-Circle that ONE option and insert both husband and wife's initials next to YES.
-Circle the remaining options as NO and insert both husband and wife's initials next to
NO.
-If you choose to donate to another couple please follow the remaining instructions
after that option.
YES________

initials
YES________

initials
YES________

initials

NO________
initials

For use in approved research.

NO________
initials

For thawing without undergoing any further
development or utilization.

NO________
initials

For use by another couple selected by The Jones
Institute, the identity of such couple to be
forever unknown to us. **

*'* If you have chosen to donate to another couple indicate below a secondary
option to be implemented 2 years from this date if we cannot find another
couple who will accept your frozen embryos.
YES_______

initials
YES_______

initials

NO________ For use in approved research.
initials
NO________ For thawing without undergoing any further
initials
development or utilization.
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We make this gift and transfer freely, without inducement or compensation, and with full
knowledge o f the finality of our gift.

(Wife's signature)

(Husband's signature)

(date)

(date)

State o f_____________________________________
City of____________________________________________ , to wit:
Subscribed and sworn before me this________ day o f

, 19_____ by

________________________________ and____________________________________

Notary Public_______________________________ My commissionexpires:_________
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APPENDIX C

Table 6 presents the results of the FISH analysis of each individual
blastomere in 65 human embryos derived from oocytes that were either
Metaphase I or Metaphase II at aspiration. Table 7 presents the results of the
FISH analysis of each individual blastomere in 61 human embryos derived from
oocytes that were Prophase I at aspiration. We include this information
because as our knowledge of human embryology increases, our concept of a
“normal" embryo is likely to change. We may wish to reevaluate these data.
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TABLE 6. FISH Analysis of Embryos in the Mature Group
# Anuclear # Nucleated
Cells
Cells
Complement for X,Y and 18 c
XX1818, XX1818, XX1818, XX1818
0
4
3
3
XXXX18181818, X18, XXXX18181818
0
2
XY1818, MNB d (XY1818, XY1818)
0
MNB (X1818, X18)
1
2
4
MNB ( - e , XX). XXX181818. MNB (-, X18), X18

Embryo # *
1-1
1-2
1-3

Total#
Cells b
4
6
2

1-4
1-5

1
6

1-6
1-7
1-8
1-9
1-10
1-11
1-12
1-13
1-14
1-15

4
3
5
2
1
4
2
6
2
8

2
0
3
0
0
0
1
3
1
4

2
3
2
2
1
4
1
3
1
4

1-16
1-17
1-18
2-19
3-20
3-21
3-22
4-23
4-24
4-25
5-26
5-27

3
6
4
7
6
3
7
4
2
4
10
10

2
4
2
2
1
0
0
1
0
0
0
7

1
2
2
5
5
3
7
3
2
4
10
3

XXXY181818, MNB (XY1818. XXX18)
MNB (XY1818, XY1818). XY1818. XY1818
LOST. XX18
XX18, MNB (-. XX, X)
XXYY18181818
XX1818, XX1818, XX1818, XX1818
Fragsf (XY181B)
XX1818, XX1818, X18
Frags (X[16l °18[16])
MNB (XX1818, XX1818), X1818, MNB (XX1818, XX1818).
MNB (XX1818, XX1818)
Frags (XXYY18181818)
MNB (XXYY1818.1818). XXYY18181818
Frags (XXY). XI5]Y[5118[0]
XXXX181818, XXXX18181818, X18. X18
XY1818. XY1818. X1818. XY1818. XY1818
XY1818, MNB (XY1818. X1818). XY1818
XX1818. XX1818, XX1818, XX1818, X1818. XX1818. XX1818
X1818, XY1818. XY1818
MNB (XX1818, XX1818). MNB (XXX1818, XX1818)
XY1818, XY1818, XY1818, XY18
XY1818. X18. XY1818. XY18. XY1818. Y18, XY1818.18. XY1818. X18
MNB (XX1818,1818), Frags (X181818). Frags (XX1818)

Classification
Normal
Mosaic
Abnormal
Didn't Cleave
Abnormal
Abnormal
Mosaic
Tech Failure
Abnormal
Didn't Cleave
Normal
Abnormal
Mosaic
Abnormal
Abnormal
Abnormal
Abnormal
Abnormal
Mosaic
Normal
Mosaic
Normal
Normal
Abnormal
Normal
Mosaic
Abnormal
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TABLE 6. FISH Analysis of Embryos in the Mature Group

Embryo #
5-28
6-29
6-30
7-31
8-32
9-33
9-34

Total #
Cells

# Anuclear # Nucleated
Cells
Cells

5
8
4
8
4
12
6

0
0
0
0
3
2
1

4
8
4
5
1
10
5

10-35
10-36
10-37
11-38
11-39
11-40

6
6
8
6
5
4

0
4
7
0
0
0

6
2
1
6
5
4

11-41
11-42

4
7

1
0

3
7

11-43

5

0

5

12-44
12-45
12-46
12-47
12-48
12-49
12-50
12-51
13-52

7
6
5
4
1
10
7
6
7

0
1
1
0
0
2
0
1
3

7
4
4
4
1
8
7
5
4

Complement for X,Y and 18
Classification
XY1818, XY1818, XY1818, XY1818
Normal
X1818, X18, X1818, XX1818, XX1818, X181818, X1818. X1818
Mosaic
XX1818, XX1818, XX1818, XX1818
Normal
XY1818, XY1818, XY1818. XY1818, XY18
Normal
MNB (XY1818, XXY181818)
Abnormal
XY1818, X1818, XY18, X1818. Y. Y. X1818. X1818, XY1818, X18
Mosaic
XY1818, XY1818, MNB (XXXYYY18181818, XXYY18181818), XY1818,
Mosaic
XY1818
MMB (Y. Y, X18), XY1818, X1818, MNB (X18, -), Y 1 8.18
Mosaic
1818, MNB (XX1818, X)
Abnormal
LOST
Tech Failure
XXX181818. X1818, X1818. XXX181818, XX18, XX18
Mosaic
XX1818, XX1818, XX1818, XX1818. XX181818
Normal
MNB (XY1818, X18), MNB (XYY1818, XYY1818),
Abnormal
MNB (XY1818, XY1818), MNB (XY1818. cvto)
XY1818, MNB (XY18, X181818), XY1818
Mosaic
MNB (X1818, XY1818), XY1818, XY1818, X1818, XY1818, XY1818,
Mosaic
XY1818
MNB (XY1818, X1818), MNB (XY1818, XY1818), MNB (XY1818, XY1818),
Abnormal
XY1818, XY1818
XX1818, XX1818, XX1818, XX1818, XX1818, XX1818, XX1818
Normal
X18, XY1818, MNB (XY1818. XY1818). meta:XY18
Mosaic
XX1818, XX1818, XX1818, MNB overlapping (XXXX181818)
Mosaic
MNB (XX18.18, XX1818), XX1818, XX1818, X1818
Mosaic
XXXY18181818
Oidnt Cleave
XX1818, MNB (X18, X18), X18, XX1818. XX1818, XX1818. XX1818, X18
Mosaic
XX1818, XX1818, XX1818, XX1818, XX18. XX1818, XX1818
Normal
-, MNB (X1818, X18), Y18, XY18, Y18
Mosaic
MNB (XX1818, X 18,18), MNB (X. XX18, -). XX18, X18
Abnormal

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

TABLE 6. FISH Analysis of Embryos in the Mature Group

Embryo #
13-53
13-54
14-55
14-56
15-57
15-58
15-59
15-60
16-61
16-62
16-63
17-64
17-65

Total #
Cells

# Anuclear # Nucleated
Cells
Cells

4
7

0
1

4
6

5
6
4
7
2
3
3
3
4
6
4

1
0
1
3
0
2
1
0
1
5
3

4
6
3
4
2
1
2
3
3
1
1

Complement for X,Y and 18
Frags (XY18), Frags (18). Frags (XY), Frags (XY18)
XY1818, MNB (X, Y, -), XY18181818, XY181818, MNB (X18, X),
XY18181818
XY1818, XY1818, XY1818, meta:XY18
XX1818, XX1818, X18, XX1818. MNB (X18, X18), XX1818
XXX1818, MNB (18, X18. X1818), XX1818
XX1818. XX1818, XX1818. XX1818
MNB (X1818. XX18, XX1818. XX1818), XX18
Multiple signals for X,18 (no Y)
MNB (X18, XX18), Frags (XXX181818)
MNB (XYY181818,1818), X18, XXY1818
XY1818, XY1818, XY1818
MNB (XXX181818, -, X181818, XX181818)
XXX181818

Classification
Abnormal
Mosaic
Normal
Mosaic
Mosaic
Normal
Abnormal
Abnormal
Abnormal
Mosaic
Normal
Abnormal
Abnormal

a : The first num ber indicates the number o f the patient from which the embryo w as obtained, and the num ber following the hyphen
represents consecutive numbering of the em bryos analyzed.
b : W hen the Total # of Cells is greater than the sum of the # Anuclear and the # Nucleated, one or m ore blastomeres w ere lost during analysis.
c : Genetic com plem ents of the individual blastomeres are separated by com m as
d : M NB indicates a multinucleated blastomere. The genetic complem ents of each individual nucleus is contained within the parenthesis
separated by com m as.
*

:

Indicates nuclei in which there w ere no signals.

': Frags indicates a blastomere with a fragm ented nucleus. T h e total number of signals observed is contained within the parenthesis.
9 . T he number in th e brackets indicates th e total number of signals for the preceding chromosome.

co

ro
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Table 7. FISH Analysis of Embryos in the Immature Group

Embryo # *
1-1
1-2
1-3

Total #
Cells b
4
5
1

# Anuclear # Nucleated
Cells
Cells
1

3

1
0
0
2

2-6
2-7
3-8
4-9
4-10
4-11
5-12
5-13
5-14
5-15
6-16

1
4
5
4
8
8
13
5
6
5
5
2
8

2
3
3
4
10
3
2
2
4
1
0

4
1
1
2
3
1
5
4
3
2
4
3
1
1
8

6-17

12

2

10

6-18

6

3

3

6-19

4

1

3

6-20

9

2

7

7-21
8-22

8
7

4
0

4
7

2-4
2-5

Complement for X,Y and 1 8 c
Fragsf (XXYY18181818), XY1818,1818
Frags (XX1818), Frags (XX1818), Frags (XX1818), Frags (XX1818)
Frags (-)e
Frags (-)
MNBd overlapping (X[8|9 Y[4]18[12]), Frags (X[4]Y(1118[6])
Frags (Xf4lY[8l18[4l). Frags (18171). MNB (18. XX)
XXXYY181818
XX1818. XXXX181818, MNB (XX18181818. XX1818). XX1818, Frags
XX1818, XX1818, XX1818, XXX1818
Frags (-), Frags (XY1818), MNB (XY18.1818)
XXXXYY18181818, Frags (XXYY18I51)
XXXYY181818, XY1818, XXXYY181818. XY1818
XXYYY18I81. XXX. X[91
Frags (X[8118[61)
MNB (XI5]Y(3]18[3], XXX)
LOST. XXX181818, XXX181818. LOST, XXX181818, XXX181818, LOST,
XXX181818
XXY181818, XY1818, XY1818, XY1818, Frags (-), Y1818, YY18[5], MNB
(XY18, X). LOST. LOST
XXXYYY18[7J, MNB (XY1818, XY1818), MNB (XXYY18181818,
XXYY18181818)
MNB (X[6]1818, XYYY18I5], XYY18, YY18), XXXY18,
MNB (Y18,1818, 18. -,-)
XY1818, XY1818, XY1818, MNB (XYY181818. -. XY1818, -),
Frags (XY1818), XY1818, XY1818
Frags (-), Frags (X1818), Frags (XY18). Frags (1818)
LOST, MNB (XY. 18), MNB (-.XY18), XY1818, XY1818, XY1818,
Frags (XY1818)

Classification
Mosaic
Abnormal
Didn't Cleave
Didn't Cleave
Abnormal
Abnormal
Abnormal
Mosaic
Normal
Abnormal
Abnormal
Mosaic
Mosaic
Abnormal
Abnormal
Aneuploid
Mosaic
Abnormal
Abnormal
Mosaic
Abnormal
Abnormal
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Table 7. FISH Analysis of Embryos in the Immature Group
Embryo #

Total#
Cells

# Anuclear # Nucleated
Cells
Cells

9-23
10-24

5
12

4
0

1
12

10-25

8

3

5

10-26
11-27
12-28

7
5
8

5
2
1

2
3
7

12-29
12-30
13-31
13-32
14-33
15-34
15-35
16-36
16-37
16-38
17-39
18-40
19-41
20-42
21-43

3
8
8
2
4
3
5
2
7
2
4
2
4
2
8

2
1
6
0
1
0
4
0
2
1
2
0
3
1
2

1
7
2
2
3
3
1
2
5
1
2
2
1
1
6

21-44

6

0

6

21-45
21-46

7
4

2
0

5
4

Complement for X,Y and 18
Classification
Frags (XXXYYY181818)
Abnormal
XX1818, XX1818, XX18, XX1818, X18, XX18, X1818,
Mosaic
MNB (XX181818, X), X1818, XX1818, meta:XX1818, XX1818
MNB (XXX181818, XXXX18), Frags (X18), MNB (XX1818, -), MNB (X18, X, Abnormal
XX18), 1818
Frags (XXXYY18181818, Frags (XY181818)
Abnormal
X1818, MNB (X18,18.
XY1818
Mosaic
Abnormal
-. XX1818, Frags (X18), Frags (X18), Frags (XX18), Frags (XX1818). XX18
XX1818
Abnormal
XX1818, cyto, XX1818, XX181818, XX1818. XX1818, XX1818
Normal
MNB (1818, XX, X). Frags (XXX1818)
Abnormal
meta: X18181818. Frags (Xf10]18[10]
Abnormal
MNB (meta: YY1818, X1818). Frags (-). Frags (-)
Abnormal
Frags (X1818), MNB (X. XY18,1818, -). X18
Abnormal
Frags (XY1818)
Abnormal
X[8]18[5], MNB (XXX1818, XXX18181818, XXX18181818)
Abnormal
18. Frags (XY1818). Frags (XY18). Frags (XYY18181818). X1818
Abnormal
LOST
Tech Failure
MNB (XX18181818, X), X18
Abnormal
Frags (XX1818). Frags (X)
Abnormal
Frags (XX1818)
Abnormal
MNB (X18, XY1818, Y18, -)
Abnormal
XXY18181818, MNB (XX, XX1818, 1818), Frags (XX181818), YYY1818,
Mosaic
XXY18181818, XYYY1818
XY1818, Frags (XYY1818), MNB (XY1818, XY1818), Frags (-), MNB
Abnormal
(181818, XY), XY1818
MNB (1818, X). Frags (XXXY181818), XXXYY1818, meta:-, meta:Y18
Abnormal
Frags (YY), Frags (XXXY18181818), Frags (XX), meta:Abnormal
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Table 7. FISH Analysis of Embryos in the Immature Group
# Anuclear # Nucleated
Cells
Cells
1
4
0
1
3
1
3
4
0
7
1
4

Embryo #
21-47
21-48
22-49
22-50
23-51
24-52

Total #
Cells
5
1
4
7
7
5

25-53

8

0

8

25-54
25-55

8
8

3
0

5
8

26-56

5

0

5

26-57
26-58
26-59
26-60

4
6
5
5

0
1
3
1

4
5
2
4

27-61

8

7

1

Complement for X,Y and 18
XX18, Frags (XXXX1818), Frags (X1818), Frags (18)
XXXX18181818, Frags (X1818)
Frags (XXYY1818), Frags (XYY181818), Frags (XXYY181818)
MNB (-, XXX18[61), XX18, XX18[5], XX18, XX18, meta: XX18, XX181818
Frags (Y18181818), Frags (XXY), MNB (XXYY, 18181818), Frags
(XXYY181818)
X1818, XYY18181818, X1818, MNB (XYY1818, X18), X1818,
MNB (Y1818, XY, Y). X1818, XY1818
XI611818, Frags (XX1818). XXXX1818, X1818, Frags (X18)
X[6]18181818, MNB (XX, 18, XX1818, -), XX1818, meta: XX1818, XX1818,
XXX181818, XX1818, XX1818
MNB (XXX181818, XX18), MNB (X18, -), XX18181818, MNB (1818, -),
1818
XYY18I61, XXXYYY181818, XY181818, X1818
X1818, meta: X1818. X1818, Frags (XXX18). Frags (X18)
MNB (Y18, -. 18). Frags (X[5118[5]
Frags (XX181818), XXX18, MNB (XXX18181818.18),
MNB (X18, X, XX18,1818, X1818, -)
MNB (XXY18181818, X{6]Y[7118(9]

Classification
Abnormal
Didn't Cleave
Abnormal
Abnormal
Mosaic
Abnormal
Mosaic
Mosaic
Mosaic
Abnormal
Mosaic
Aneuploid
Abnormal
Abnormal
Abnormal

a . The first num ber indicates the num ber of the patient from which the em bryo w as obtained, and the num ber following the hyphen
represents consecutive numbering of the em bryos analyzed.
b : W hen the Total # of Cells is greater than the sum of the # Anuclear and the # Nucleated, one or m ore blastomeres w ere lost during analysis.
c : G enetic com plem ents of the individual blastomeres are separated by com m as.
d : M NB indicates a multinucleated blastomere. T he genetic complem ents of each individual nucleus is contained within the parenthesis
separated by comm as.
e:

Indicates nuclei in which there w ere no signals.

' : Frags indicates a blastom ere with a fragm ented nucleus. The total num ber of signals observed is contained within the parenthesis.
a : The num ber in the brackets indicates the total number of signals for the preceding chromosome.
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